Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	hemoglobin alpha binding	HBB HBD HBG1 HBG2	3.03e-08	5	178	4	GO:0031721
GeneOntologyMolecularFunction	ATP-dependent activity	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B CHD1 SMARCAD1 ABCA10 DDX10 CCT6A MDN1 SHOC1 NAV1 KIF14 MACF1 TOR1B DNAH5 DHX34 DNAH8 ATP2B1 HSPA7	3.12e-08	614	178	22	GO:0140657
GeneOntologyMolecularFunction	actin filament binding	MYH2 MICAL1 MYH3 MYH6 MYH9 MYH10 MYO7B SYNE1 FHOD3 SPTBN4 SHROOM4 EGFR MACF1	1.33e-07	227	178	13	GO:0051015
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH3 CHD1 SMARCAD1 ABCA10 DDX10 CCT6A MDN1 SHOC1 NAV1 KIF14 MACF1 TOR1B DNAH5 DHX34 DNAH8 ATP2B1 HSPA7	4.63e-07	441	178	17	GO:0016887
GeneOntologyMolecularFunction	follicle-stimulating hormone receptor binding	MYH9 ARRB1 ARRB2	6.97e-07	3	178	3	GO:0031762
GeneOntologyMolecularFunction	microfilament motor activity	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B	1.00e-06	38	178	6	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B KIF14 DNAH5 DNAH8	1.13e-06	118	178	9	GO:0003774
GeneOntologyMolecularFunction	haptoglobin binding	HBB HBD HBG1 HBG2	1.23e-06	10	178	4	GO:0031720
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH2 MICAL1 MYH3 MYH6 MYH9 MYH10 MYO7B SYNE1 CAPN1 TRPC6 NUMA1 FHOD3 PICALM DRG1 CEP350 SPTBN4 SHROOM4 SAG EGFR SNX6 SORBS3 PKD2 KIF14 MACF1 TOR1B EML1 EPB41	1.61e-06	1099	178	27	GO:0008092
GeneOntologyMolecularFunction	hemoglobin binding	HBB HBD HBG1 HBG2	1.92e-06	11	178	4	GO:0030492
GeneOntologyMolecularFunction	oxygen carrier activity	HBB HBD HBG1 HBG2	5.70e-06	14	178	4	GO:0005344
GeneOntologyMolecularFunction	oxygen binding	CYP8B1 HBB HBD HBG1 HBG2	1.84e-05	37	178	5	GO:0019825
GeneOntologyMolecularFunction	clathrin binding	TRPC6 PICALM CEMIP ARRB1 SCLT1 LMBRD1	2.06e-05	63	178	6	GO:0030276
GeneOntologyMolecularFunction	actin binding	MYH2 MICAL1 MYH3 MYH6 MYH9 MYH10 MYO7B SYNE1 TRPC6 FHOD3 SPTBN4 SHROOM4 EGFR MACF1 EPB41	2.69e-05	479	178	15	GO:0003779
GeneOntologyMolecularFunction	pyrophosphatase activity	MYH3 HBS1L CHD1 SMARCAD1 ABCA10 ITPA DRG1 DDX10 CCT6A MDN1 SHOC1 NAV1 KIF14 MACF1 TOR1B DNAH5 DHX34 DNAH8 ATP2B1 HSPA7	6.19e-05	839	178	20	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	MYH3 HBS1L CHD1 SMARCAD1 ABCA10 ITPA DRG1 DDX10 CCT6A MDN1 SHOC1 NAV1 KIF14 MACF1 TOR1B DNAH5 DHX34 DNAH8 ATP2B1 HSPA7	6.29e-05	840	178	20	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	MYH3 HBS1L CHD1 SMARCAD1 ABCA10 ITPA DRG1 DDX10 CCT6A MDN1 SHOC1 NAV1 KIF14 MACF1 TOR1B DNAH5 DHX34 DNAH8 ATP2B1 HSPA7	6.29e-05	840	178	20	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	MYH3 HBS1L CHD1 SMARCAD1 ABCA10 DRG1 DDX10 CCT6A MDN1 SHOC1 NAV1 KIF14 MACF1 TOR1B DNAH5 DHX34 DNAH8 ATP2B1 HSPA7	6.60e-05	775	178	19	GO:0017111
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	7.90e-05	2	178	2	GO:0016639
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	7.90e-05	2	178	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	7.90e-05	2	178	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	7.90e-05	2	178	2	GO:0004354
GeneOntologyMolecularFunction	hemoglobin beta binding	HBB HBD	7.90e-05	2	178	2	GO:0031722
GeneOntologyMolecularFunction	alpha-1A adrenergic receptor binding	ARRB1 ARRB2	7.90e-05	2	178	2	GO:0031691
GeneOntologyMolecularFunction	clathrin heavy chain binding	PICALM CEMIP LMBRD1	1.44e-04	12	178	3	GO:0032050
GeneOntologyMolecularFunction	alpha-1B adrenergic receptor binding	ARRB1 ARRB2	2.36e-04	3	178	2	GO:0031692
GeneOntologyMolecularFunction	molecular carrier activity	IPO5 RANBP6 HBB HBD HBG1 HBG2	4.16e-04	108	178	6	GO:0140104
GeneOntologyMolecularFunction	tetrapyrrole binding	CYP8B1 HBB HBD HBG1 HBG2 LMBRD1 SDHD	6.83e-04	164	178	7	GO:0046906
GeneOntologyMolecularFunction	ADP binding	MYH9 MYH10 GLUD1 GLUD2	8.75e-04	48	178	4	GO:0043531
GeneOntologyMolecularFunction	calmodulin binding	MYH2 MYH3 MYH6 MYH9 MYH10 EGFR ATP2B1 EPB41	1.09e-03	230	178	8	GO:0005516
GeneOntologyMolecularFunction	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity	B4GAT1 B3GNT2	1.16e-03	6	178	2	GO:0008532
GeneOntologyMolecularFunction	ubiquitin-modified histone reader activity	UIMC1 USP15	1.61e-03	7	178	2	GO:0061649
GeneOntologyMolecularFunction	L-leucine binding	GLUD1 GLUD2	1.61e-03	7	178	2	GO:0070728
GeneOntologyMolecularFunction	antioxidant activity	PRXL2A HBB HBD HBG1 HBG2	1.77e-03	97	178	5	GO:0016209
GeneOntologyMolecularFunction	carbohydrate binding	MANBA ALPK1 GFPT1 FREM1 NOMO1 CEMIP NOMO2 CRYBG3 NOMO3	1.91e-03	310	178	9	GO:0030246
GeneOntologyMolecularFunction	heme binding	CYP8B1 HBB HBD HBG1 HBG2 SDHD	2.61e-03	154	178	6	GO:0020037
GeneOntologyMolecularFunction	peroxidase activity	HBB HBD HBG1 HBG2	2.71e-03	65	178	4	GO:0004601
GeneOntologyMolecularFunction	oxidoreductase activity, acting on peroxide as acceptor	HBB HBD HBG1 HBG2	3.02e-03	67	178	4	GO:0016684
GeneOntologyMolecularFunction	angiotensin receptor binding	ARRB1 ARRB2	3.39e-03	10	178	2	GO:0031701
GeneOntologyMolecularFunction	histone H4K20 methyltransferase activity	NSD2 SMYD5	3.39e-03	10	178	2	GO:0042799
GeneOntologyMolecularFunction	spectrin binding	SPTBN4 SAG EPB41	3.40e-03	34	178	3	GO:0030507
GeneOntologyBiologicalProcess	oxygen transport	HBB HBD HBG1 HBG2	6.65e-06	15	177	4	GO:0015671
GeneOntologyBiologicalProcess	actomyosin structure organization	MYH3 MYH6 MYH9 MYH10 FHOD3 RHPN1 ARRB1 BRAF SORBS3 CGNL1 EPB41	7.24e-06	239	177	11	GO:0031032
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	MYH9 RSPH4A NUMA1 HAUS3 DRG1 CEP350 FSIP2 TBC1D32 NSFL1C SLC16A1 PKD2 NAV1 KIF14 CEP152 EML1 PARD3 CFAP44 DNAH5 DNAH8	1.45e-05	720	177	19	GO:0000226
GeneOntologyBiologicalProcess	carbon dioxide transport	HBB HBD HBG1 HBG2	1.84e-05	19	177	4	GO:0015670
GeneOntologyBiologicalProcess	follicle-stimulating hormone signaling pathway	MYH9 ARRB1 ARRB2	3.37e-05	8	177	3	GO:0042699
GeneOntologyBiologicalProcess	microtubule bundle formation	RSPH4A NUMA1 FSIP2 TBC1D32 NAV1 CFAP44 DNAH5 DNAH8	3.68e-05	145	177	8	GO:0001578
GeneOntologyBiologicalProcess	actin filament-based process	MYH2 MICAL1 MYH3 MYH6 MYH9 MYH10 MYO7B CAPN1 FHOD3 SPTBN4 SHROOM4 RHPN1 ARRB1 BRAF KCNJ2 SORBS3 PRKG1 CGNL1 POTEJ PARD3 EPB41	3.82e-05	912	177	21	GO:0030029
GeneOntologyBiologicalProcess	microtubule-based process	MYH9 RSPH4A ACTR10 NUMA1 HAUS3 NSUN7 DRG1 CEP350 FSIP2 TBC1D32 NSFL1C SLC16A1 PKD2 NAV1 KIF14 MACF1 CEP152 IFT80 EML1 PARD3 CFAP44 DNAH5 DNAH8	3.90e-05	1058	177	23	GO:0007017
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO1 NOMO2 NOMO3	5.02e-05	9	177	3	GO:0160063
GeneOntologyBiologicalProcess	actin filament-based movement	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B KCNJ2 PARD3	5.39e-05	153	177	8	GO:0030048
GeneOntologyBiologicalProcess	gas transport	HBB HBD HBG1 HBG2	6.76e-05	26	177	4	GO:0015669
GeneOntologyBiologicalProcess	ovulation cycle	MYH9 STAT5A STAT5B ARRB1 ARRB2 EGFR	1.70e-04	95	177	6	GO:0042698
GeneOntologyBiologicalProcess	one-carbon compound transport	HBB HBD HBG1 HBG2	1.77e-04	33	177	4	GO:0019755
GeneOntologyBiologicalProcess	hydrogen peroxide catabolic process	HBB HBD HBG1 HBG2	1.77e-04	33	177	4	GO:0042744
GeneOntologyBiologicalProcess	actin cytoskeleton organization	MICAL1 MYH3 MYH6 MYH9 MYH10 MYO7B CAPN1 FHOD3 SPTBN4 SHROOM4 RHPN1 ARRB1 BRAF SORBS3 PRKG1 CGNL1 POTEJ EPB41	1.96e-04	803	177	18	GO:0030036
GeneOntologyBiologicalProcess	supramolecular fiber organization	COL6A1 MICAL1 MYH3 MYH6 MYH9 MYH10 MYO7B CAPN1 NUMA1 FHOD3 HAUS3 DRG1 SPTBN4 SHROOM4 RHPN1 ARRB1 BRAF SORBS3 KIF14 CGNL1	2.17e-04	957	177	20	GO:0097435
GeneOntologyBiologicalProcess	development of secondary male sexual characteristics	STAT5A STAT5B	2.18e-04	3	177	2	GO:0046544
GeneOntologyBiologicalProcess	actin filament bundle distribution	MYH9 MYH10	2.18e-04	3	177	2	GO:0070650
GeneOntologyBiologicalProcess	actin filament bundle assembly	MICAL1 MYH9 MYH10 RHPN1 ARRB1 BRAF SORBS3 CGNL1	2.51e-04	191	177	8	GO:0051017
GeneOntologyBiologicalProcess	muscle filament sliding	MYH2 MYH3 MYH6	2.62e-04	15	177	3	GO:0030049
GeneOntologyBiologicalProcess	establishment of organelle localization	MYH9 MYH10 SYNE1 ACTR10 NUMA1 EIPR1 PICALM DSN1 MDN1 NSFL1C SNX6 KIF14 EXOC1 PARD3	2.73e-04	546	177	14	GO:0051656
GeneOntologyBiologicalProcess	hydrogen peroxide metabolic process	EGFR HBB HBD HBG1 HBG2	2.76e-04	67	177	5	GO:0042743
GeneOntologyBiologicalProcess	actin filament bundle organization	MICAL1 MYH9 MYH10 RHPN1 ARRB1 BRAF SORBS3 CGNL1	2.89e-04	195	177	8	GO:0061572
GeneOntologyBiologicalProcess	ovulation cycle process	MYH9 STAT5A STAT5B ARRB1 ARRB2	2.96e-04	68	177	5	GO:0022602
GeneOntologyBiologicalProcess	organelle assembly	MYH3 MYH6 MYH10 RSPH4A SYNE1 NUMA1 FHOD3 HAUS3 ALPK1 DRG1 CEP350 FSIP2 TBC1D32 MDN1 NSFL1C PAN2 CEP152 IFT80 SCLT1 CFAP44 DNAH5 DNAH8	3.10e-04	1138	177	22	GO:0070925
GeneOntologyBiologicalProcess	axoneme assembly	RSPH4A FSIP2 TBC1D32 CFAP44 DNAH5 DNAH8	3.58e-04	109	177	6	GO:0035082
GeneOntologyCellularComponent	myosin complex	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B CGNL1	6.28e-07	59	176	7	GO:0016459
GeneOntologyCellularComponent	myosin filament	MYH2 MYH3 MYH6 MYH9 MYH10	1.85e-06	25	176	5	GO:0032982
GeneOntologyCellularComponent	haptoglobin-hemoglobin complex	HBB HBD HBG1 HBG2	2.28e-06	12	176	4	GO:0031838
GeneOntologyCellularComponent	hemoglobin complex	HBB HBD HBG1 HBG2	2.28e-06	12	176	4	GO:0005833
GeneOntologyCellularComponent	myosin II complex	MYH2 MYH3 MYH6 MYH9 MYH10	3.36e-06	28	176	5	GO:0016460
GeneOntologyCellularComponent	supramolecular fiber	COL6A1 MYH2 MICAL1 MYH3 MYH6 MYH9 MYH10 PYROXD1 SYNE1 NUMA1 FHOD3 HAUS3 SPTBN4 SHROOM4 CCT6A SHANK2 SYNJ2 UNC45B NAV1 KIF14 MACF1 EML1 POTEJ DNAH5 DNAH8	1.91e-05	1179	176	25	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	COL6A1 MYH2 MICAL1 MYH3 MYH6 MYH9 MYH10 PYROXD1 SYNE1 NUMA1 FHOD3 HAUS3 SPTBN4 SHROOM4 CCT6A SHANK2 SYNJ2 UNC45B NAV1 KIF14 MACF1 EML1 POTEJ DNAH5 DNAH8	2.14e-05	1187	176	25	GO:0099081
GeneOntologyCellularComponent	actin cytoskeleton	MYH2 MICAL1 MYH3 MYH6 MYH9 MYH10 MYO7B ACTR10 TOPBP1 FHOD3 SPTBN4 SHROOM4 MACF1 CGNL1 POTEJ EPB41	3.09e-05	576	176	16	GO:0015629
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	4.75e-05	9	176	3	GO:0160064
GeneOntologyCellularComponent	spindle	MYH9 MYH10 NUMA1 TOPBP1 HAUS3 ALPK1 DSN1 CEP350 NSFL1C PKD2 KIF14 EML1 PARD3 EPB41	4.77e-05	471	176	14	GO:0005819
GeneOntologyCellularComponent	cell cortex	MYH2 MYH9 MYH10 NUMA1 SPTBN4 SHROOM4 PKD2 MACF1 EXOC1 TNFAIP2 PARD3 EPB41	7.58e-05	371	176	12	GO:0005938
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	1.99e-04	14	176	3	GO:0072379
GeneOntologyCellularComponent	myosin II filament	MYH9 MYH10	2.10e-04	3	176	2	GO:0097513
GeneOntologyCellularComponent	dendritic spine	MYH10 ASIC2 SYNE1 ANKS1B ARRB1 ARRB2 SHANK2 KCNJ2 ATP2B1	2.19e-04	242	176	9	GO:0043197
GeneOntologyCellularComponent	neuron spine	MYH10 ASIC2 SYNE1 ANKS1B ARRB1 ARRB2 SHANK2 KCNJ2 ATP2B1	2.54e-04	247	176	9	GO:0044309
GeneOntologyCellularComponent	muscle myosin complex	MYH2 MYH3 MYH6	3.03e-04	16	176	3	GO:0005859
GeneOntologyCellularComponent	cortical cytoskeleton	MYH2 MYH9 NUMA1 SPTBN4 SHROOM4 EPB41	7.91e-04	129	176	6	GO:0030863
GeneOntologyCellularComponent	actomyosin contractile ring	MYH2 MYH9	1.44e-03	7	176	2	GO:0005826
GeneOntologyCellularComponent	brush border	MYH9 MYH10 MYO7B LCT SLC3A1 SHANK2	1.84e-03	152	176	6	GO:0005903
MousePheno	asymmetric snout	HBS1L FREM1 EGFR	1.08e-05	5	145	3	MP:0008862
MousePheno	abnormal cerebral cortex pyramidal cell morphology	MANBA CNTN6 EPG5 BRAF KIF14	1.80e-05	32	145	5	MP:0009969
Domain	Myosin_tail_1	MYH2 MYH3 MYH6 MYH9 MYH10 CGNL1	1.05e-08	18	175	6	PF01576
Domain	Myosin_tail	MYH2 MYH3 MYH6 MYH9 MYH10 CGNL1	1.05e-08	18	175	6	IPR002928
Domain	Haemoglobin_b	HBB HBD HBG1 HBG2	3.70e-08	5	175	4	IPR002337
Domain	Myosin_N	MYH2 MYH3 MYH6 MYH9 MYH10	1.90e-07	15	175	5	PF02736
Domain	Myosin_N	MYH2 MYH3 MYH6 MYH9 MYH10	1.90e-07	15	175	5	IPR004009
Domain	IQ	MYH2 MYH3 MYH6 MYH9 MYH10 RASGRF1 MYO7B UBE3C	3.26e-07	71	175	8	PF00612
Domain	Myosin-like_IQ_dom	MYH2 MYH3 MYH6 MYH9 MYH10	7.13e-07	19	175	5	IPR027401
Domain	-	MYH2 MYH3 MYH6 MYH9 MYH10	7.13e-07	19	175	5	4.10.270.10
Domain	IQ	MYH2 MYH3 MYH6 MYH9 MYH10 RASGRF1 MYO7B UBE3C	9.09e-07	81	175	8	SM00015
Domain	Myosin_head_motor_dom	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B	1.34e-06	38	175	6	IPR001609
Domain	MYOSIN_MOTOR	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B	1.34e-06	38	175	6	PS51456
Domain	Myosin_head	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B	1.34e-06	38	175	6	PF00063
Domain	MYSc	MYH2 MYH3 MYH6 MYH9 MYH10 MYO7B	1.34e-06	38	175	6	SM00242
Domain	IQ_motif_EF-hand-BS	MYH2 MYH3 MYH6 MYH9 MYH10 RASGRF1 MYO7B UBE3C	2.04e-06	90	175	8	IPR000048
Domain	IQ	MYH2 MYH3 MYH6 MYH9 MYH10 RASGRF1 MYO7B UBE3C	2.62e-06	93	175	8	PS50096
Domain	DUF2012	NOMO1 NOMO2 NOMO3	3.21e-06	4	175	3	PF09430
Domain	Arrestin_N	SAG ARRB1 ARRB2	3.21e-06	4	175	3	IPR014753
Domain	Arrestin_CS	SAG ARRB1 ARRB2	3.21e-06	4	175	3	IPR017864
Domain	ARRESTINS	SAG ARRB1 ARRB2	3.21e-06	4	175	3	PS00295
Domain	Arrestin	SAG ARRB1 ARRB2	3.21e-06	4	175	3	IPR000698
Domain	-	SAG ARRB1 ARRB2	3.21e-06	4	175	3	2.60.40.840
Domain	DUF2012	NOMO1 NOMO2 NOMO3	3.21e-06	4	175	3	IPR019008
Domain	Globin	HBB HBD HBG1 HBG2	3.48e-06	12	175	4	IPR000971
Domain	Globin	HBB HBD HBG1 HBG2	3.48e-06	12	175	4	PF00042
Domain	GLOBIN	HBB HBD HBG1 HBG2	3.48e-06	12	175	4	PS01033
Domain	-	HBB HBD HBG1 HBG2	4.99e-06	13	175	4	1.10.490.10
Domain	Globin/Proto	HBB HBD HBG1 HBG2	4.99e-06	13	175	4	IPR012292
Domain	Globin-like	HBB HBD HBG1 HBG2	1.24e-05	16	175	4	IPR009050
Domain	-	SAG ARRB1 ARRB2	2.75e-05	7	175	3	2.60.40.640
Domain	Arrestin_C	SAG ARRB1 ARRB2	4.37e-05	8	175	3	IPR014752
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	4.37e-05	8	175	3	IPR013784
Domain	P-loop_NTPase	MYH2 MYH3 HBS1L MYH6 MYH9 MYH10 GTPBP6 MYO7B CHD1 SMARCAD1 ABCA10 DRG1 DDX10 MDN1 NAV1 KIF14 TOR1B DNAH5 DHX34 DNAH8 NLRP8	4.68e-05	848	175	21	IPR027417
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	8.73e-05	2	175	2	PF02812
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	8.73e-05	2	175	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	8.73e-05	2	175	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	8.73e-05	2	175	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	8.73e-05	2	175	2	PF00208
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	8.73e-05	2	175	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	8.73e-05	2	175	2	PS00074
Domain	ELFV_dehydrog	GLUD1 GLUD2	8.73e-05	2	175	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	8.73e-05	2	175	2	IPR033524
Domain	Arrestin-like_N	SAG ARRB1 ARRB2	9.25e-05	10	175	3	IPR011021
Domain	Arrestin_C-like	SAG ARRB1 ARRB2	9.25e-05	10	175	3	IPR011022
Domain	Arrestin_C	SAG ARRB1 ARRB2	9.25e-05	10	175	3	SM01017
Domain	Arrestin_C	SAG ARRB1 ARRB2	9.25e-05	10	175	3	PF02752
Domain	Arrestin_N	SAG ARRB1 ARRB2	9.25e-05	10	175	3	PF00339
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	2.16e-04	13	175	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	2.16e-04	13	175	3	2.60.40.1120
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH5 DNAH8	2.73e-04	14	175	3	IPR011704
Domain	AAA_5	MDN1 DNAH5 DNAH8	2.73e-04	14	175	3	PF07728
Domain	PDZ	LNX2 SHROOM4 RHPN1 SHANK2 PATJ PARD3 SIPA1L2	3.71e-04	141	175	7	PF00595
Domain	PDZ	LNX2 SHROOM4 RHPN1 SHANK2 PATJ PARD3 SIPA1L2	4.96e-04	148	175	7	SM00228
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	4.99e-04	17	175	3	IPR008969
Domain	-	LNX2 SHROOM4 RHPN1 SHANK2 PATJ PARD3 SIPA1L2	5.38e-04	150	175	7	2.30.42.10
Domain	PDZ	LNX2 SHROOM4 RHPN1 SHANK2 PATJ PARD3 SIPA1L2	5.59e-04	151	175	7	PS50106
Domain	PDZ	LNX2 SHROOM4 RHPN1 SHANK2 PATJ PARD3 SIPA1L2	5.82e-04	152	175	7	IPR001478
Domain	Spectrin	SYNE1 SPTBN4 MACF1	1.25e-03	23	175	3	PF00435
Domain	ACTININ_2	SYNE1 SPTBN4 MACF1	1.25e-03	23	175	3	PS00020
Domain	ACTININ_1	SYNE1 SPTBN4 MACF1	1.25e-03	23	175	3	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 SPTBN4 MACF1	1.25e-03	23	175	3	IPR001589
Domain	STAT_TF_DNA-bd_sub	STAT5A STAT5B	1.78e-03	7	175	2	IPR012345
Domain	STAT	STAT5A STAT5B	1.78e-03	7	175	2	IPR001217
Domain	STAT_int	STAT5A STAT5B	1.78e-03	7	175	2	SM00964
Domain	STAT_TF_DNA-bd	STAT5A STAT5B	1.78e-03	7	175	2	IPR013801
Domain	STAT_bind	STAT5A STAT5B	1.78e-03	7	175	2	PF02864
Domain	STAT_int	STAT5A STAT5B	1.78e-03	7	175	2	PF02865
Domain	-	STAT5A STAT5B	1.78e-03	7	175	2	1.10.532.10
Domain	STAT_alpha	STAT5A STAT5B	1.78e-03	7	175	2	PF01017
Domain	-	STAT5A STAT5B	1.78e-03	7	175	2	1.20.1050.20
Domain	STAT_TF_prot_interaction	STAT5A STAT5B	1.78e-03	7	175	2	IPR013799
Domain	STAT_TF_coiled-coil	STAT5A STAT5B	1.78e-03	7	175	2	IPR015988
Domain	-	STAT5A STAT5B	1.78e-03	7	175	2	2.60.40.630
Domain	Pept_cys_AS	CAPN1 CAPN11 DNAH8	2.23e-03	28	175	3	IPR000169
Domain	STAT_TF_alpha	STAT5A STAT5B	2.36e-03	8	175	2	IPR013800
Domain	DHC_N1	DNAH5 DNAH8	2.36e-03	8	175	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH5 DNAH8	2.36e-03	8	175	2	IPR013594
Domain	AAA	ABCA10 MDN1 NAV1 TOR1B DNAH5 DNAH8	2.38e-03	144	175	6	SM00382
Domain	AAA+_ATPase	ABCA10 MDN1 NAV1 TOR1B DNAH5 DNAH8	2.38e-03	144	175	6	IPR003593
Domain	Spectrin_repeat	SYNE1 SPTBN4 MACF1	2.47e-03	29	175	3	IPR002017
Domain	Actin	ACTR8 ACTR10 POTEJ	3.00e-03	31	175	3	IPR004000
Domain	Actin	ACTR8 ACTR10 POTEJ	3.00e-03	31	175	3	PF00022
Domain	ACTIN	ACTR8 ACTR10 POTEJ	3.00e-03	31	175	3	SM00268
Domain	CH	MICAL1 SYNE1 SPTBN4 MACF1	3.23e-03	65	175	4	SM00033
Domain	-	FSTL5 CAPN1 DGKB STAT5A STAT5B CAPN11 PKD2 MACF1	3.27e-03	261	175	8	1.10.238.10
Domain	SPEC	SYNE1 SPTBN4 MACF1	3.28e-03	32	175	3	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 SPTBN4 MACF1	3.28e-03	32	175	3	IPR018159
Pathway	KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B PRLR	8.66e-06	5	136	3	M49006
Pathway	KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY	STAT5A STAT5B EGFR	2.99e-05	7	136	3	M47430
Pathway	KEGG_TIGHT_JUNCTION	MYH2 MYH3 MYH6 MYH9 MYH10 PATJ PARD3 EPB41	4.12e-05	132	136	8	M11355
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	UIMC1 MYH2 MYH3 MYH6 MYH9 MYH10 GTPBP6 PYROXD1 NSD2 SYNE1 NUMA1 ANKS1B PABPC5 HP1BP3 CAPN11 SPTBN4 CCT6A ARRB1 MDN1 SHANK2 GLUD1 GLUD2 MACF1 POTEJ SIPA1L2 DTHD1 TASOR DNAH8 ATP2B1	3.39e-10	1442	179	29	35575683
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	HBS1L MYH10 VPS13C ACTR10 HAUS3 RUFY1 GFPT1 CEP350 CCT6A IBTK NSFL1C SYNJ2 NOMO2 KIF14 TMEM131 CEP152 CGNL1 UBE3C SIPA1L2 SCLT1 USP15 EPB41	6.44e-10	853	179	22	28718761
Pubmed	The mouse globin pseudogene beta h3 is descended from a premammalian delta-globin gene.	HBB HBD HBG1 HBG2	6.79e-10	4	179	4	6092350
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CDK17 SYNE1 CHD1 SMARCAD1 STT3A HP1BP3 NOMO1 DRG1 DDX10 SNW1 MDN1 NSFL1C EGFR SNX6 SLC16A1 NOMO2 MAP4K5 NUP210 GLUD1 MACF1 TMEM131 IFT80 CRYBG3 SLC30A9 PARD3 SIPA1L2 ATP2B1 GOLGA3	3.03e-09	1487	179	28	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CUL4A MYH10 GTPBP6 NSD2 VPS13C CAPN1 EIPR1 STT3A STAT5B HP1BP3 SPTBN4 ARRB1 ARRB2 SHANK2 ZNF33B EGFR SYNJ2 NUP210 PKD2 NAV1 MACF1 UBE3C CSMD1 PATJ PARD3 USP15 ATP2B1 EPB41	3.12e-09	1489	179	28	28611215
Pubmed	The 3' splice site of pre-messenger RNA is recognized by a small nuclear ribonucleoprotein.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	2933810
Pubmed	Direct sequencing of enzymatically amplified human genomic DNA.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	3267215
Pubmed	A fusion gene in man: DNA sequence analysis of the abnormal globin gene of hemoglobin Miyada.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6324786
Pubmed	mRNA precursor splicing in vivo: sequence requirements determined by deletion analysis of an intervening sequence.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	3857622
Pubmed	G to A substitution in the distal CCAAT box of the A gamma-globin gene in Greek hereditary persistence of fetal haemoglobin.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	2578619
Pubmed	A point mutation in the A gamma-globin gene promoter in Greek hereditary persistence of fetal haemoglobin.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	2578620
Pubmed	Duplication followed by deletion accounts for the structure of an Indian deletion beta (0)-thalassemia gene.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	7162987
Pubmed	mRNA-deficient beta o-thalassemia results from a single nucleotide deletion.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6292840
Pubmed	Epsilon globin gene transcripts originating upstream of the mRNA cap site in K562 cells and normal human embryos.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6292831
Pubmed	Unexpected relationships between four large deletions in the human beta-globin gene cluster.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6652684
Pubmed	Cloning specific complete polyadenylylated 3'-terminal cDNA segments.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	2581851
Pubmed	Human beta-globin messenger RNA. I. Nucleotide sequences derived from complementary RNA.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	873928
Pubmed	beta 0 thalassemia, a nonsense mutation in man.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	88735
Pubmed	Molecular characterization of seven beta-thalassemia mutations in Asian Indians.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6714226
Pubmed	Hemoglobin Long Island is caused by a single mutation (adenine to cytosine) resulting in a failure to cleave amino-terminal methionine.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	3455755
Pubmed	Human fetal globin DNA sequences suggest novel conversion event.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6330670
Pubmed	Beta-thalassemia due to a T----A mutation within the ATA box.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	3382401
Pubmed	Nucleotide sequence of the BALB/c mouse beta-globin complex.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	2926808
Pubmed	The structure and expression of the haemoglobin genes.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6297279
Pubmed	Nonsense and frameshift mutations in beta 0-thalassemia detected in cloned beta-globin genes.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6985481
Pubmed	Nonsense mutation as a cause of beta 0 thalassemia.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6985475
Pubmed	Identification of a retrovirus-like repetitive element in human DNA.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6095301
Pubmed	A transient definitive erythroid lineage with unique regulation of the β-globin locus in the mammalian embryo.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	21378272
Pubmed	A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6210198
Pubmed	Transcriptional interference among the murine beta-like globin genes.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	17077320
Pubmed	Extensive movement of LINES ONE sequences in beta-globin loci of Mus caroli and Mus domesticus.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	2905421
Pubmed	An intron nucleotide sequence variant in a cloned beta +-thalassaemia globin gene.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6264391
Pubmed	A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	7151176
Pubmed	A naturally occurring deletion in the mouse Hbbs beta-globin gene cluster.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	3459181
Pubmed	A weak upstream promoter gives rise to long human beta-globin RNA molecules.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6303333
Pubmed	Beta + thalassemia: aberrant splicing results from a single point mutation in an intron.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6895866
Pubmed	Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	7557375
Pubmed	The beta-globin gene in Sardinian delta beta 0-thalassemia carries a C----T nonsense mutation at codon 39.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6327288
Pubmed	beta-Thalassemia present in cis to a new beta-chain structural variant, Hb Vicksburg [beta 75 (E19)Leu leads to 0].	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6165992
Pubmed	beta zero thalassemia in Sardinia is caused by a nonsense mutation.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6457059
Pubmed	Cryptic branch point activation allows accurate in vitro splicing of human beta-globin intron mutants.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	3879973
Pubmed	The "beta-like-globin" gene domain in human erythroid cells.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	3879975
Pubmed	Base substitution at position -88 in a beta-thalassemic globin gene. Further evidence for the role of distal promoter element ACACCC.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6086605
Pubmed	Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6280057
Pubmed	A nucleotide change at a splice junction in the human beta-globin gene is associated with beta 0-thalassemia.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6270663
Pubmed	Alternative sites of transcription initiation upstream of the canonical cap site in human gamma-globin and beta-globin genes.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6701091
Pubmed	Developmental regulation of a complete 70-kb human beta-globin locus in transgenic mice.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	1383089
Pubmed	The deletion in a type of delta 0-beta 0-thalassaemia begins in an inverted AluI repeat.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6184621
Pubmed	Structure and expression of a cloned beta o thalassaemic globin gene.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6272205
Pubmed	Molecular cloning and characterization of the human beta-like globin gene cluster.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6155216
Pubmed	DNA sequence organization of the beta-globin complex in the BALB/c mouse.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6250710
Pubmed	Multiple origins of transcription in the 4.5 Kb upstream of the epsilon-globin gene.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6194897
Pubmed	Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	8649401
Pubmed	Human beta-globin promoter and coding sequences transcribed by RNA polymerase III.	HBB HBD HBG1 HBG2	3.38e-09	5	179	4	6194893
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	IPO5 HBS1L MYH9 MYH10 NSD2 VPS13C SYNE1 NUMA1 CHD1 SMARCAD1 PSMD11 GFPT1 STT3A NOMO1 DRG1 DDX10 CCT6A SNW1 MDN1 SLC16A1 NUP210 GLUD1 KIF14 UBE3C DNAH5 GCN1 ATP2B1	5.27e-09	1425	179	27	30948266
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 COL6A1 MYH9 UBQLN4 RREB1 RUFY1 KMT2D ARRB2 SLC16A1 NAV1 KIF14 CRYBG3 TASOR GCN1 GOLGA3	5.32e-09	418	179	15	34709266
Pubmed	"Maturational" globin switching in primary primitive erythroid cells.	HBB HBD HBG1 HBG2	1.01e-08	6	179	4	16263786
Pubmed	The structure and evolution of the human beta-globin gene family.	HBB HBD HBG1 HBG2	1.01e-08	6	179	4	6985477
Pubmed	Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells.	HBB HBD HBG1 HBG2	1.01e-08	6	179	4	17655922
Pubmed	A novel strategy to identify maternal and paternal inheritance in the mouse.	HBB HBD HBG1 HBG2	1.01e-08	6	179	4	7588571
Pubmed	Multiple hematopoietic defects and delayed globin switching in Ikaros null mice.	HBB HBD HBG1 HBG2	1.01e-08	6	179	4	11805317
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	PDXDC1 IPO5 HBS1L MYH9 PSMD11 RUFY1 PICALM STAT5A CCT6A NSFL1C SNX6 USP15 GCN1 GOLGA3 EPB41	1.38e-08	449	179	15	31732153
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CUL4A CDK17 ALPK1 CEP350 FSIP2 MDN1 BRAF SLC16A1 SYNJ2 NAV1 KIF14 MACF1 CEP152 CGNL1 CRYBG3 PATJ PARD3 SIPA1L2 ATP2B1 EPB41	2.32e-08	861	179	20	36931259
Pubmed	ZNF410 represses fetal globin by singular control of CHD4.	HBB HBD HBG1 HBG2	2.35e-08	7	179	4	33859416
Pubmed	Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.	HBB HBD HBG1 HBG2	2.35e-08	7	179	4	21127173
Pubmed	Developmental and species-divergent globin switching are driven by BCL11A.	HBB HBD HBG1 HBG2	2.35e-08	7	179	4	19657335
Pubmed	Strict in vivo specificity of the Bcl11a erythroid enhancer.	HBB HBD HBG1 HBG2	2.35e-08	7	179	4	27707736
Pubmed	Early mammalian erythropoiesis requires the Dot1L methyltransferase.	HBB HBD HBG1 HBG2	2.35e-08	7	179	4	20798234
Pubmed	Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci.	HBB HBD HBG1 HBG2	2.35e-08	7	179	4	9887104
Pubmed	Sox6 directly silences epsilon globin expression in definitive erythropoiesis.	HBB HBD HBG1 HBG2	2.35e-08	7	179	4	16462943
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IPO5 CDK17 MICAL1 MYH6 MYH9 MYH10 SYNE1 ANKS1B DGKB HP1BP3 SPTBN4 CCT6A SHANK2 SRGAP3 GLUD1 GLUD2 NAV1 MACF1 EXOC1 CGNL1 SIPA1L2 HBB HBD ATP2B1 GOLGA3 CACNA2D3	2.43e-08	1431	179	26	37142655
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TOPBP1 CEMIP SPTBN4 SYNJ2 NAV1 MACF1 CEP152 IFT80 TASOR	2.67e-08	130	179	9	12421765
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYH10 SYNE1 FSTL5 DGKB GON4L SMARCAD1 EPG5 SRGAP3 PCDH19 NAV1 MACF1 UBE3C SIPA1L2 USP15	2.97e-08	407	179	14	12693553
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	IPO5 MYH9 MYH10 CAPN1 PSMD11 PICALM STAT5B DRG1 CCT6A MDN1 NUP210 GLUD1 MACF1 USP15 HBG1 HBG2 GCN1 EPB41	3.10e-08	707	179	18	19738201
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	IPO5 MYH9 MYH10 ANXA3 EIPR1 NOMO1 ARRB2 MDN1 NOMO2 GLUD1 GLUD2 GCN1 NOMO3	3.16e-08	344	179	13	30333137
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	IPO5 HBS1L MYH9 NUMA1 GFPT1 STT3A CCT6A NSFL1C EGFR SLC16A1 MAP4K5 MACF1 CRYBG3 PATJ PARD3 GCN1 ATP2B1 EPB41	3.17e-08	708	179	18	39231216
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CUL4A UIMC1 NSD2 TOPBP1 GON4L HAUS3 CEP350 ARRB2 NSFL1C GLUD2 NAV1 KIF14 CEP152 EXOC1 HBB USP15 EPB41	4.66e-08	645	179	17	25281560
Pubmed	A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E.	HBS1L HBD HBG1 HBG2	4.67e-08	8	179	4	20183929
Pubmed	Cis-regulatory mechanisms governing stem and progenitor cell transitions.	HBB HBD HBG1 HBG2	4.67e-08	8	179	4	26601269
Pubmed	Targeted deletion of Nm23/nucleoside diphosphate kinase A and B reveals their requirement for definitive erythropoiesis in the mouse embryo.	HBB HBD HBG1 HBG2	4.67e-08	8	179	4	19235734
Pubmed	UCP2 modulates cell proliferation through the MAPK/ERK pathway during erythropoiesis and has no effect on heme biosynthesis.	HBB HBD HBG1 HBG2	4.67e-08	8	179	4	18687678
Pubmed	Real-time PCR for single-cell genotyping in sickle cell and thalassemia syndromes as a rapid, accurate, reliable, and widely applicable protocol for preimplantation genetic diagnosis.	HBB HBD HBG1 HBG2	4.67e-08	8	179	4	15108284
Pubmed	Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript.	HBB HBD HBG1 HBG2	4.67e-08	8	179	4	29866654
Pubmed	Protein phosphatase 2A catalytic subunit α (PP2Acα) maintains survival of committed erythroid cells in fetal liver erythropoiesis through the STAT5 pathway.	STAT5A HBB HBD HBG1 HBG2	4.97e-08	20	179	5	21514445
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	IPO5 USP34 KDM3A DCHS2 ACTR8 B4GAT1 GTPBP6 RBL2 SYNE1 UBQLN4 ANKS1B SMARCAD1 GFPT1 STAT5B CEP350 SPTBN4 ARRB1 SNX6 NOMO2 GLUD1 MACF1 TMEM131 EXOC1 GOLGA3	5.34e-08	1285	179	24	35914814
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	IPO5 HBS1L MYH9 MYH10 NUMA1 GFPT1 STT3A HP1BP3 DRG1 SNW1 SRGAP3 NAV1 MACF1 GCN1 EPB41	5.37e-08	498	179	15	36634849
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IPO5 USP34 MYH9 MYH10 NSD2 CAPN1 NUMA1 CHD1 GFPT1 HP1BP3 DDX10 SNW1 MDN1 NUP210 KIF14 MACF1 GCN1	5.56e-08	653	179	17	22586326
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	PDXDC1 HBS1L B4GAT1 VPS13C PRXL2A PICALM DSN1 ARRB2 SNW1 NSFL1C EGFR SNX6 SLC16A1 NOMO2 MAP4K5 NUP210 SORBS3 KIF14 TMEM131 GOLGA3 EPB41	6.32e-08	1007	179	21	34597346
Pubmed	Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	7926723
Pubmed	3' non-coding region sequences in eukaryotic messenger RNA.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	822353
Pubmed	Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	9887098
Pubmed	Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	7753194
Pubmed	A mutant mouse with severe anemia and skin abnormalities controlled by a new allele of the flaky skin (fsn) locus.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	16093647
Pubmed	Peroxidase activity of hemoglobin-haptoglobin complexes: covalent aggregation and oxidative stress in plasma and macrophages.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	19740759
Pubmed	Mouse Mix gene is activated early during differentiation of ES and F9 stem cells and induces endoderm in frog embryos.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	12619131
Pubmed	Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencing.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	23716600
Pubmed	Role of the GATA-1/FOG-1/NuRD pathway in the expression of human beta-like globin genes.	HBB HBD HBG1 HBG2	8.38e-08	9	179	4	20439494
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	CUL4A MYH2 MYH6 MYH9 SYNE1 CAPN1 PICALM GFPT1 CCT6A GLUD1 GLUD2 KIF14 MACF1 HBB HBD HBG1 HBG2 GCN1 HSPA7	8.67e-08	844	179	19	25963833
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	IPO5 MYH9 MYH10 PSMD11 STT3A NOMO1 CCT6A SLC16A1 NUP210 HBB GCN1 ATP2B1	1.18e-07	320	179	12	28685749
Pubmed	Selective coupling of STAT factors to the mouse prolactin receptor.	STAT5A STAT5B PRLR	1.34e-07	3	179	3	9874248
Interaction	HDAC1 interactions	CUL4A IPO5 MYH2 PADI4 MYH9 ACTR8 MYH10 NSD2 RBL2 UBQLN4 GON4L CHD1 SMARCAD1 PSMD11 RREB1 RUFY1 STAT5A TBC1D32 CCT6A KMT2D ARRB2 EGFR SLC16A1 NAV1 KIF14 PRKG1 CRYBG3 USP15 TASOR GCN1 GOLGA3	1.05e-08	1108	178	31	int:HDAC1
Interaction	KDM1A interactions	USP34 COL6A1 MYH9 NSD2 UBQLN4 HAUS3 SMARCAD1 RREB1 RUFY1 CEP350 KMT2D ARRB2 NSFL1C SLC16A1 SRGAP3 NAV1 KIF14 CEP152 EXOC1 CRYBG3 UBE3C SCLT1 USP15 TASOR GCN1 GOLGA3	2.39e-07	941	178	26	int:KDM1A
Interaction	DCTN1 interactions	CUL4A RBL2 ACTR10 PSMD11 RUFY1 CEP350 IBTK SNW1 EGFR SNX6 SYNJ2 RFXANK NAV1 KIF14 MACF1 EML1 USP15 EPB41	4.56e-07	497	178	18	int:DCTN1
Interaction	KCNJ15 interactions	MYH9 MYH10 KCNJ2 PATJ	1.19e-06	10	178	4	int:KCNJ15
Interaction	VCL interactions	CUL4A MYH6 MYH9 HAUS3 RUFY1 PICALM EGFR SORBS3 NAV1 KIF14 MACF1 CRYBG3 SIPA1L2	3.36e-06	305	178	13	int:VCL
Interaction	FLOT1 interactions	MYH9 PICALM STAT5A STAT5B EGFR SNX6 GLUD1 SORBS3 KIF14 MACF1 CRYBG3 PATJ PARD3 SIPA1L2 ATP2B1 EPB41	5.16e-06	475	178	16	int:FLOT1
Interaction	SNCA interactions	IPO5 HBS1L MYH9 MYH10 VPS13C NUMA1 RREB1 GFPT1 STT3A HP1BP3 DRG1 ARRB1 SNW1 EGFR SRGAP3 NAV1 MACF1 PATJ USP15 GCN1	5.64e-06	716	178	20	int:SNCA
Interaction	MFN2 interactions	IPO5 MYH10 PSMD11 IBTK NSFL1C EGFR KIF14 CRYBG3 GOLGA3	6.83e-06	148	178	9	int:MFN2
Interaction	MYBPC3 interactions	CUL4A MYH6 MYH9 CAPN1	9.86e-06	16	178	4	int:MYBPC3
Interaction	SYNE3 interactions	B4GAT1 VPS13C PICALM STT3A NOMO1 CEP350 NUP210 NAV1 KIF14 MACF1 TMEM131 CEP152 CGNL1 CRYBG3 SIPA1L2	9.94e-06	444	178	15	int:SYNE3
Interaction	TNFSF13B interactions	USP34 RANBP6 MDN1 KIF14 TMEM131 EXOC1 UBE3C GCN1	1.08e-05	119	178	8	int:TNFSF13B
Interaction	PHF21A interactions	USP34 EIPR1 RREB1 RUFY1 KMT2D ARRB2 SLC16A1 NAV1 KIF14 EXOC1 CRYBG3 SCLT1 GOLGA3	1.19e-05	343	178	13	int:PHF21A
Interaction	PFN1 interactions	GLRX5 MYH9 SPR VPS13C RUFY1 HP1BP3 CEP350 SNX6 SYNJ2 NAV1 KIF14 MACF1 CEP152 CRYBG3 SIPA1L2 GOLGA3	1.22e-05	509	178	16	int:PFN1
Interaction	NUF2 interactions	HAUS3 DSN1 SNW1 NSFL1C EGFR RFXANK EXOC1 SLC30A9	1.37e-05	123	178	8	int:NUF2
Interaction	PRKACA interactions	IPO5 CDK17 MYH9 MYH10 RASGRF1 PSMD11 CCT6A NSFL1C BRAF EGFR SNX6 MAP4K5 CRYBG3 PARD3 GCN1 ATP2B1	1.56e-05	519	178	16	int:PRKACA
Interaction	YWHAQ interactions	CDK17 MYH2 MYH9 SPR CAPN1 UBQLN4 NUMA1 PSMD11 RUFY1 CEP350 CCT6A ARRB1 ARRB2 BRAF EGFR SYNJ2 NAV1 KIF14 MACF1 CGNL1 PARD3 SIPA1L2 HBB GCN1 EPB41	1.76e-05	1118	178	25	int:YWHAQ
Interaction	NDC80 interactions	HAUS3 DSN1 CEP350 SNW1 EGFR SNX6 NAV1 KIF14 CEP152 EXOC1 SCLT1 GOLGA3	2.25e-05	312	178	12	int:NDC80
Interaction	TPM1 interactions	MYH2 MYH6 MYH9 STAT5B EGFR PKD2 PAN2 KIF14 SCLT1 GOLGA3 EPB41	2.31e-05	263	178	11	int:TPM1
Interaction	CAPZA1 interactions	IPO5 UIMC1 MYH9 ACTR10 NUMA1 RUFY1 CCT6A ARRB2 SNW1 B3GNT2 PAN2 KIF14 PATJ	2.36e-05	366	178	13	int:CAPZA1
Interaction	HMGCLL1 interactions	COL6A1 VPS13C CEMIP HBB	2.55e-05	20	178	4	int:HMGCLL1
Interaction	HBA1 interactions	EGFR B3GNT2 PAN2 HBB HBD HBG2	2.79e-05	67	178	6	int:HBA1
Interaction	NOMO3 interactions	TRPC6 UBQLN4 NOMO1 DRG1 BRAF NOMO3	2.79e-05	67	178	6	int:NOMO3
Interaction	GSK3B interactions	CUL4A IPO5 MICAL1 HBS1L MYH9 CAPN1 PICALM GFPT1 CEP350 SPTBN4 CCT6A IBTK ARRB1 ARRB2 NSFL1C MACF1 CEP152 CRYBG3 SIPA1L2 DHX34 GOLGA3	2.83e-05	868	178	21	int:GSK3B
Interaction	VIM interactions	MICAL1 MYH9 CAPN1 RUFY1 ABCA10 CEMIP CCT6A ARRB1 ARRB2 SNW1 BRAF EGFR SYNJ2 B3GNT2 PAN2 NAV1 KIF14 UBE3C SIPA1L2 USP15	3.01e-05	804	178	20	int:VIM
Interaction	RCOR1 interactions	USP34 MYH9 MYH10 NUMA1 EIPR1 RREB1 RUFY1 KMT2D ARRB2 SLC16A1 SCLT1 USP15 TASOR GCN1 GOLGA3	3.45e-05	494	178	15	int:RCOR1
Interaction	LATS1 interactions	CUL4A MYH2 MYH3 MYH6 GLRX5 CEP350 MDN1 SLC16A1 KIF14 CEP152 PATJ PARD3 SIPA1L2 USP15	3.83e-05	440	178	14	int:LATS1
Interaction	HIF1A interactions	IPO5 KDM3A MYH2 MYH3 MYH6 CAPN1 CEP350 ARRB1 ARRB2 NSFL1C NUP210 GLUD1 UBE3C GCN1	3.92e-05	441	178	14	int:HIF1A
Interaction	OCLN interactions	PDXDC1 PICALM SNW1 EGFR SNX6 MAP4K5 KIF14 MACF1 UBE3C PATJ PARD3 SIPA1L2 ATP2B1 GOLGA3 EPB41	3.95e-05	500	178	15	int:OCLN
Interaction	MYH9 interactions	MYH9 MYH10 PSMD11 RUFY1 PICALM DSN1 ARRB1 ARRB2 SNW1 NSFL1C EGFR PAN2 KIF14 MACF1 UBE3C USP15 DNAH5 GOLGA3 EPB41	4.05e-05	754	178	19	int:MYH9
Interaction	AFDN interactions	CUL4A ARRB2 EGFR SORBS3 KIF14 MACF1 CEP152 CGNL1 PATJ PARD3 SIPA1L2 ATP2B1	4.25e-05	333	178	12	int:AFDN
Interaction	PTPRN2 interactions	UBQLN4 SPTBN4 EGFR GLUD1 GCN1 ATP2B1	4.55e-05	73	178	6	int:PTPRN2
Interaction	ANAPC2 interactions	CUL4A SMARCAD1 DRG1 CEP350 EGFR SYNJ2 KIF14 CEP152 SIPA1L2 GOLGA3	4.56e-05	234	178	10	int:ANAPC2
Interaction	NCAPD2 interactions	IPO5 MYH9 MYH10 SNW1 EGFR KCNJ2 RFXANK KIF14 USP15 GOLGA3	4.56e-05	234	178	10	int:NCAPD2
Interaction	TCOF1 interactions	GLRX5 MYH9 MYH10 NSD2 ARRB1 ARRB2 EGFR PAN2 KIF14 TASOR CACNA2D3	5.99e-05	292	178	11	int:TCOF1
Interaction	MYL3 interactions	CUL4A MYH6 MYH9 MYH10	6.44e-05	25	178	4	int:MYL3
Interaction	NUMA1 interactions	CUL4A IPO5 MYH10 NSD2 UBQLN4 NUMA1 SMARCAD1 HP1BP3 DDX10 SNX6 NUP210 KIF14 MACF1 EPB41	7.59e-05	469	178	14	int:NUMA1
Interaction	SAG interactions	SAG ARRB1 ARRB2	7.77e-05	10	178	3	int:SAG
Interaction	PTPRN interactions	IPO5 UBQLN4 RANBP6 SPTBN4 NUP210 KIF14 UBE3C	8.17e-05	117	178	7	int:PTPRN
Interaction	NIN interactions	ACTR10 HAUS3 GFPT1 CEP350 CCT6A SNW1 NOMO2 KIF14 CEP152 CGNL1 SIPA1L2 SCLT1	8.71e-05	359	178	12	int:NIN
Interaction	EEF1AKMT3 interactions	PDXDC1 USP34 ACTR8 VPS13C SMARCAD1 RUFY1 CCT6A MDN1 NAV1 PATJ GCN1 HSPA7	9.93e-05	364	178	12	int:EEF1AKMT3
Interaction	PTPRH interactions	IPO5 EGFR GLUD1 UBE3C GCN1 ATP2B1	1.00e-04	84	178	6	int:PTPRH
Interaction	CFTR interactions	PDXDC1 IPO5 MYH2 MYH3 MYH6 MYH9 MYH10 PYROXD1 ANXA3 CAPN1 PABPC5 PSMD11 GFPT1 DRG1 MDN1 EGFR SLC16A1 UNC45B NUP210 SORBS3 MACF1 TOR1B PRKG1 UBE3C HBB HBD GCN1 ATP2B1	1.04e-04	1480	178	28	int:CFTR
Interaction	PSMC5 interactions	IPO5 MYH9 MYH10 UBQLN4 PSMD11 RUFY1 SNW1 EGFR PAN2 KIF14 PRKG1 UBE3C HBB USP15	1.06e-04	484	178	14	int:PSMC5
Interaction	AMOT interactions	UIMC1 RUFY1 CEP350 NAV1 KIF14 CEP152 CRYBG3 PATJ PARD3 SIPA1L2 SCLT1	1.08e-04	312	178	11	int:AMOT
Interaction	SIRT7 interactions	CUL4A IPO5 USP34 MYH9 MYH10 NSD2 CAPN1 NUMA1 CHD1 GFPT1 HP1BP3 DDX10 SNW1 MDN1 NUP210 KIF14 MACF1 GCN1	1.09e-04	744	178	18	int:SIRT7
Interaction	RPN1 interactions	IPO5 LNX2 UBQLN4 RUFY1 PICALM STT3A NOMO1 DRG1 CCT6A EGFR NOMO2 B3GNT2 NUP210 GLUD2 KIF14 TMEM131 SLC30A9 ATP2B1 LMBRD1	1.11e-04	814	178	19	int:RPN1
Interaction	CD70 interactions	PDXDC1 RANBP6 RUFY1 MDN1 B3GNT2 TNFAIP2 UBE3C SLC30A9	1.17e-04	166	178	8	int:CD70
Interaction	DIRAS3 interactions	IPO5 PICALM NSFL1C EGFR SNX6 MAP4K5 MACF1 PARD3 ATP2B1 GOLGA3	1.17e-04	262	178	10	int:DIRAS3
Interaction	MOB2 interactions	MYH9 MYH10 ITPA NSFL1C GLUD1 ATP2B1	1.22e-04	87	178	6	int:MOB2
Interaction	HUWE1 interactions	IPO5 USP34 KDM3A HBS1L MYH9 CAPN1 SMARCAD1 PSMD11 RUFY1 STT3A HP1BP3 DRG1 CCT6A SNW1 NSFL1C EGFR SLC16A1 NOMO2 RFXANK B3GNT2 MACF1 USP15 GCN1	1.24e-04	1110	178	23	int:HUWE1
Interaction	TOM1L1 interactions	STAT5B NOMO1 EGFR GLUD2 TASOR NOMO3	1.30e-04	88	178	6	int:TOM1L1
Interaction	DVL2 interactions	UIMC1 VPS13C SYNE1 NUMA1 PSMD11 FREM1 ARRB1 ARRB2 SNW1 SNX6 RFXANK SORBS3 MACF1 CGNL1 PARD3	1.32e-04	557	178	15	int:DVL2
Interaction	ZNF598 interactions	IPO5 HBS1L MYH9 MYH10 PSMD11 STT3A NOMO1 CCT6A SLC16A1 NUP210 HBB GCN1 ATP2B1	1.36e-04	435	178	13	int:ZNF598
Interaction	SPTAN1 interactions	MYH9 CAPN1 SPTBN4 ARRB1 ARRB2 SNW1 NSFL1C EGFR PCDH19 B3GNT2 PAN2 KIF14 EXOC1 EPB41	1.37e-04	496	178	14	int:SPTAN1
Interaction	KXD1 interactions	LRRC45 NUMA1 EIPR1 RUFY1 EXOC1 IFT80 EML1 GOLGA3	1.37e-04	170	178	8	int:KXD1
Interaction	CEP135 interactions	HAUS3 CEP350 IBTK GLUD2 NAV1 KIF14 TMEM131 CEP152 CGNL1 SIPA1L2	1.59e-04	272	178	10	int:CEP135
Interaction	ENO1 interactions	CUL4A IPO5 GLRX5 MYH9 MYH10 NSD2 NUMA1 ITPA NOMO1 EGFR SNX6 NOMO2 FARS2 B3GNT2 KIF14 USP15 DNAH8	1.66e-04	701	178	17	int:ENO1
Interaction	MKRN2 interactions	MYH9 MYH10 PABPC5 CEMIP TBC1D32 EGFR PAN2 MACF1 PRKG1 EML1 PARD3 ATP2B1	1.68e-04	385	178	12	int:MKRN2
Interaction	H2AC4 interactions	CUL4A IPO5 MICAL1 ACTR8 MYH10 UBQLN4 NUMA1 GON4L HP1BP3 KMT2D MDN1 KIF14 DNAH5 ATP2B1	1.68e-04	506	178	14	int:H2AC4
Interaction	EED interactions	PDXDC1 CUL4A IPO5 MYH9 ACTR8 MYH10 NSD2 VPS13C ACTR10 CAPN1 NUMA1 SMARCAD1 PSMD11 PICALM GFPT1 HP1BP3 DDX10 CCT6A BRAF SNX6 SLC16A1 UNC45B B3GNT2 NUP210 MACF1 CGNL1 UBE3C	1.72e-04	1445	178	27	int:EED
Interaction	ARRDC3 interactions	PDXDC1 NUMA1 ARRB1 ARRB2 SNW1 SLC16A1 UBE3C PARD3 GCN1	1.75e-04	224	178	9	int:ARRDC3
Interaction	RAB35 interactions	PDXDC1 VPS13C RUFY1 PICALM ITPA EGFR SNX6 SLC16A1 MAP4K5 KIF14 MACF1 PARD3 ATP2B1 GOLGA3 EPB41	1.80e-04	573	178	15	int:RAB35
Interaction	PSMD12 interactions	CUL4A IPO5 UBQLN4 PSMD11 SNW1 NSFL1C EGFR KIF14 UBE3C USP15 TASOR	1.81e-04	331	178	11	int:PSMD12
Interaction	RPGRIP1L interactions	CUL4A HAUS3 PSMD11 CEP350 IBTK KIF14 CEP152 SIPA1L2 ATP2B1	1.81e-04	225	178	9	int:RPGRIP1L
Interaction	PSMD3 interactions	IPO5 MYH9 SPR UBQLN4 PSMD11 RUFY1 GFPT1 SNW1 EGFR B3GNT2 UBE3C USP15	1.89e-04	390	178	12	int:PSMD3
Interaction	MED4 interactions	HAUS3 CEP350 ARRB2 NSFL1C EGFR GLUD2 NAV1 KIF14 CEP152 EXOC1 HBB USP15 EPB41	1.90e-04	450	178	13	int:MED4
Interaction	H2BC8 interactions	CUL4A UIMC1 MYH9 NSD2 NUMA1 TOPBP1 GON4L CHD1 SMARCAD1 RREB1 HP1BP3 EPG5 DDX10 SNW1 TASOR	1.90e-04	576	178	15	int:H2BC8
Interaction	CBX3 interactions	CUL4A UIMC1 KDM3A NSD2 NUMA1 TOPBP1 CHD1 SMARCAD1 RREB1 DSN1 HP1BP3 SNW1 EGFR KIF14 MACF1 PRKG1	2.05e-04	646	178	16	int:CBX3
Interaction	ECPAS interactions	CUL4A UIMC1 KDM3A MYH10 SYNE1 PSMD11 IBTK BRAF EGFR B3GNT2 CEP152	2.11e-04	337	178	11	int:ECPAS
Interaction	MCM2 interactions	CUL4A MYH2 MYH6 MYH9 SYNE1 CAPN1 NUMA1 PICALM GFPT1 CCT6A EGFR GLUD1 GLUD2 KIF14 MACF1 HBB HBD USP15 HBG1 HBG2 GCN1 HSPA7	2.27e-04	1081	178	22	int:MCM2
Interaction	GOLGA1 interactions	PDXDC1 RUFY1 CEP350 NAV1 MACF1 CEP152 CRYBG3 GOLGA3	2.28e-04	183	178	8	int:GOLGA1
Interaction	MYL12B interactions	MYH9 MYH10 ARRB1 EGFR PAN2 KIF14 USP15	2.28e-04	138	178	7	int:MYL12B
Interaction	NEURL2 interactions	MYH3 MYH6 EGFR	2.30e-04	14	178	3	int:NEURL2
Interaction	PSMC6 interactions	CUL4A MYH9 MYH10 UBQLN4 PSMD11 RUFY1 SNW1 NSFL1C EGFR KIF14 UBE3C	2.40e-04	342	178	11	int:PSMC6
Interaction	LCK interactions	STAT5A DRG1 CCT6A EGFR SNX6 NAV1 KIF14 MACF1 CRYBG3 PARD3 SIPA1L2 ATP2B1 GOLGA3	2.50e-04	463	178	13	int:LCK
Interaction	MAPK9 interactions	LNX2 RHPN1 ARRB1 ARRB2 EGFR MACF1 STK40 SCLT1	2.54e-04	186	178	8	int:MAPK9
Interaction	GSK3A interactions	HBS1L PICALM CEP350 IBTK ARRB2 SNW1 MDN1 GLUD1 MACF1 CEP152 CRYBG3 SIPA1L2 GOLGA3	2.55e-04	464	178	13	int:GSK3A
Interaction	KCNA3 interactions	IPO5 HBS1L MYH9 NUMA1 GFPT1 STT3A CCT6A NSFL1C EGFR SLC16A1 MAP4K5 MACF1 CRYBG3 PATJ PARD3 DNAH5 GCN1 ATP2B1 EPB41	2.64e-04	871	178	19	int:KCNA3
Interaction	DNAJA1 interactions	MYH9 MYH10 PSMD11 RUFY1 CCT6A SNW1 BRAF EGFR B3GNT2 PAN2 STK40 HBB USP15 GOLGA3	2.86e-04	533	178	14	int:DNAJA1
Interaction	PRMT5 interactions	CUL4A KDM3A MYH9 MYH10 CAPN1 PSMD11 RUFY1 ARRB1 ARRB2 NSFL1C EGFR PAN2 USP15	2.95e-04	471	178	13	int:PRMT5
Interaction	GORASP1 interactions	PDXDC1 RUFY1 RHPN1 SNX6 KIF14 GOLGA3	3.07e-04	103	178	6	int:GORASP1
Interaction	S100A2 interactions	IPO5 UIMC1 CDK17 SYNE1 HAUS3 PSMD11 DSN1 CEP350 KMT2D CRYBG3 DHX34 GOLGA3	3.11e-04	412	178	12	int:S100A2
Interaction	VCAM1 interactions	IPO5 MYH9 MYH10 CAPN1 PSMD11 PICALM STAT5B DRG1 CCT6A MACF1 HBG1 HBG2 GCN1	3.20e-04	475	178	13	int:VCAM1
Interaction	MAP1B interactions	CUL4A MYH9 NSD2 SYNE1 PSMD11 DRG1 CCT6A ARRB1 ARRB2 SLC16A1 B3GNT2 GLUD1 GLUD2 PAN2	3.20e-04	539	178	14	int:MAP1B
Interaction	GGH interactions	PDXDC1 MANBA RUFY1 NOMO1 EGFR B3GNT2 TMEM131 TOR1B NOMO3	3.20e-04	243	178	9	int:GGH
Interaction	COPS3 interactions	CUL4A MYH9 PSMD11 IBTK SNW1 EGFR HBB USP15 GOLGA3	3.40e-04	245	178	9	int:COPS3
Interaction	RTF1 interactions	NUMA1 CHD1 ARRB1 ARRB2 EGFR SNX6 TASOR	3.80e-04	150	178	7	int:RTF1
Interaction	NPM1 interactions	CUL4A IPO5 MICAL1 PADI4 MYH10 NSD2 NUMA1 RANBP6 CHD1 RUFY1 HP1BP3 DDX10 ARRB1 ARRB2 BRAF EGFR B3GNT2 GLUD2 PAN2 KIF14 CEP152 USP15 GOLGA3	3.86e-04	1201	178	23	int:NPM1
Interaction	SHC1 interactions	MYH9 MYH10 ANKS1B STAT5A STAT5B CCT6A EGFR MAP4K5 KIF14 SCLT1 USP15	3.89e-04	362	178	11	int:SHC1
Interaction	GSPT1 interactions	IPO5 HBS1L MYH9 PSMD11 DRG1 SNW1 EGFR GLUD1 PAN2 USP15	4.06e-04	306	178	10	int:GSPT1
Interaction	HAPSTR1 interactions	IPO5 USP34 HBS1L HAUS3 SMARCAD1 PSMD11 PICALM STT3A DRG1 CCT6A SNX6 PAN2 KIF14 POTEJ PATJ USP15 GCN1 GOLGA3	4.07e-04	829	178	18	int:HAPSTR1
Interaction	RAB11A interactions	PDXDC1 MYH9 MYH10 VPS13C ACTR10 RANBP6 RUFY1 PICALM STT3A EGFR SNX6 SLC16A1 MAP4K5 EXOC1 CRYBG3 ATP2B1 GOLGA3 EPB41	4.13e-04	830	178	18	int:RAB11A
Interaction	ASF1B interactions	IPO5 NUMA1 PSMD11 RUFY1 STAT5B PAN2	4.17e-04	109	178	6	int:ASF1B
Interaction	CIT interactions	IPO5 HBS1L MYH9 MYH10 SYNE1 NUMA1 CHD1 RREB1 PICALM GFPT1 HP1BP3 DRG1 DDX10 SPTBN4 CCT6A SNW1 SLC16A1 NUP210 GLUD1 KIF14 MACF1 POTEJ PATJ PARD3 GCN1 HSPA7	4.33e-04	1450	178	26	int:CIT
Interaction	TMPO interactions	MYH9 MYH10 NSD2 CHD1 SMARCAD1 RUFY1 GFPT1 HP1BP3 ARRB1 ARRB2 SNW1 B3GNT2 GLUD1 KIF14 TMEM131 GCN1 GOLGA3	4.36e-04	762	178	17	int:TMPO
Interaction	SARS2 interactions	RUFY1 CCT6A EGFR GLUD1 KIF14 USP15	4.37e-04	110	178	6	int:SARS2
Interaction	DYNC1H1 interactions	IPO5 ACTR10 NUMA1 PSMD11 RUFY1 ARRB2 EGFR KIF14 STK40 SCLT1 USP15 GCN1 EPB41	4.37e-04	491	178	13	int:DYNC1H1
Interaction	HMGN5 interactions	CUL4A NSD2 UBQLN4 NUMA1 PSMD11 HP1BP3 GLUD1	4.45e-04	154	178	7	int:HMGN5
Interaction	MYL6 interactions	MYH9 MYH10 RUFY1 ARRB1 ARRB2 PAN2 KIF14 PARD3 USP15	4.55e-04	255	178	9	int:MYL6
Interaction	CD274 interactions	CUL4A IPO5 CAPN1 UBQLN4 STT3A CCT6A GLUD1 KIF14 EXOC1 UBE3C GCN1	4.56e-04	369	178	11	int:CD274
GeneFamily	Myosin heavy chains	MYH2 MYH3 MYH6 MYH9 MYH10	2.84e-08	15	116	5	1098
GeneFamily	Hemoglobin subunits	HBB HBD HBG1 HBG2	3.28e-07	10	116	4	940
GeneFamily	Classical arrestins	SAG ARRB1 ARRB2	1.02e-06	4	116	3	1312
GeneFamily	PDZ domain containing	LNX2 SHROOM4 RHPN1 SHANK2 PATJ PARD3 SIPA1L2	5.60e-05	152	116	7	1220
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	USP34 CDK17 KDM3A TOPBP1 CHD1 PICALM DDX10 CEMIP CEP350 IBTK SNW1 MDN1 EGFR SYNJ2 FARS2 MAP4K5 PKD2 KIF14 MACF1 TMEM131 CRYBG3 PARD3 USP15 TASOR ATP2B1	8.84e-10	856	178	25	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	CDK17 TOPBP1 CHD1 PICALM CEMIP CEP350 IBTK MDN1 EGFR FARS2 MAP4K5 PKD2 KIF14 TMEM131 PARD3 TASOR ATP2B1	2.22e-08	466	178	17	M13522
Coexpression	DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP	CUL4A IPO5 HBS1L PYROXD1 TOPBP1 RREB1 PICALM ITPA STAT5A STAT5B HP1BP3 NOMO1 DRG1 DDX10 CCT6A ARRB1 SNW1 SLC16A1 FARS2 MAP4K5 B3GNT2 GLUD1 SLC30A9 HBB HBD HBG1 EPB41 SDHD	2.74e-07	1399	178	28	M535
Coexpression	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	NUMA1 PICALM DDX10 SDHD	7.36e-06	19	178	4	M13194
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	USP34 NSD2 TOPBP1 ALPK1 HP1BP3 SNW1 IFT80 STK40 SCLT1	7.60e-06	194	178	9	M7467
Coexpression	ZHENG_BOUND_BY_FOXP3	CDK17 KDM3A HBS1L LNX2 RBL2 TLR6 STAT5B IBTK SAG B3GNT2 MACF1 IFT80 ATP2B1 EPB41	8.47e-06	498	178	14	M1741
Coexpression	GSE20727_CTRL_VS_H2O2_TREATED_DC_UP	MANBA VPS13C NUMA1 RUFY1 STAT5A EPG5 BRAF TASOR EPB41	8.96e-06	198	178	9	M9245
Coexpression	ZHENG_BOUND_BY_FOXP3	CDK17 KDM3A HBS1L LNX2 RBL2 TLR6 STAT5B IBTK SAG B3GNT2 MACF1 IFT80 ATP2B1 EPB41	1.04e-05	507	178	14	MM1030
Coexpression	HAN_SATB1_TARGETS_DN	UIMC1 SH3TC2 RBL2 NSUN7 ARRB1 SHANK2 EGFR SLC16A1 SYNJ2 HBG2 GCN1 EPB41	1.49e-05	388	178	12	M15491
Coexpression	GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN	PADI4 LRRC45 ACTR10 IBTK B3GNT2 NAV1 CEP152 CGNL1	1.71e-05	164	178	8	M6919
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	PDXDC1 NUMA1 GON4L CHD1 STAT5B HP1BP3 NOMO1 EPG5 NSFL1C NOMO2 IFT80 PATJ NOMO3	2.32e-05	474	178	13	M40991
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN	SYNE1 CCT6A B3GNT2 NUP210 TMEM131 USP15 TASOR ATP2B1	6.80e-05	199	178	8	M5201
Coexpression	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP	IPO5 HBS1L PSMD11 STAT5B SRGAP3 CGNL1 CRYBG3 UBE3C	7.04e-05	200	178	8	M3663
Coexpression	GSE17721_LPS_VS_CPG_24H_BMDC_DN	TOPBP1 HAUS3 CNTN6 SLC3A1 CCT6A TMEM131 CRYBG3 HBG2	7.04e-05	200	178	8	M4011
Coexpression	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	CUL4A MANBA NUMA1 TBC1D32 PIGX B3GNT2 STK40 DHX34	7.04e-05	200	178	8	M7868
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN	TOPBP1 PRXL2A SMYD5 PICALM STT3A CCT6A B3GNT2 CRYBG3	7.04e-05	200	178	8	M4066
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	CUL4A IPO5 PYROXD1 RBL2 NUMA1 TOPBP1 HAUS3 TLR6 CEP350 CCT6A IBTK MDN1 MAP4K5 NUP210 MACF1 TMEM131 TOR1B SLC30A9 USP15 TASOR TRIM38	8.30e-05	1215	178	21	M41122
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LNX2 SYNE1 SHANK2 EGFR STK33 PRKG1 CGNL1 PATJ PARD3 DNAH5	7.48e-09	195	180	10	9406866f99555198a9be311fbd65751b70f35446
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	LNX2 ANXA3 CNTN6 SHANK2 EGFR STK33 CGNL1 PATJ PARD3	5.08e-08	179	180	9	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LNX2 ANXA3 CNTN6 SHROOM4 SHANK2 EGFR CGNL1 PATJ PARD3	5.08e-08	179	180	9	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CUL4A GLRX5 NATD1 SLC16A1 HBB USP15 HBG1 HBG2 EPB41	5.86e-08	182	180	9	93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	LNX2 ANXA3 ANKS1B CNTN6 SHANK2 EGFR STK33 CGNL1 PATJ	6.14e-08	183	180	9	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	LNX2 ANXA3 SHANK2 EGFR STK33 CGNL1 PATJ PARD3 DNAH5	7.74e-08	188	180	9	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	LNX2 SHANK2 EGFR STK33 PRKG1 CGNL1 PATJ PARD3 DNAH5	9.26e-08	192	180	9	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Influenza_Severe-RBC\|Influenza_Severe / Disease group and Cell class	GLRX5 LNX2 NATD1 HBD MAP4K5 HBB HBG1 HBG2 EPB41	9.26e-08	192	180	9	f19b6da3fd98da1a76d2570137a8f73a3850ebcb
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK2 MYH10 ASIC2 SYNE1 ANKS1B SPTBN4 SHANK2 CSMD1 ATP2B1	1.10e-07	196	180	9	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	severe-Myeloid-Neutrophils_4\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PADI4 MYH9 NATD1 HBD NSUN7 STAT5B HBB HBG1 HBG2	1.26e-07	199	180	9	50242666def13e5d4149c563ae000d6768f086f7
ToppCell	Influenza-Influenza_Severe-Others-RBC\|Influenza_Severe / Disease, condition lineage and cell class	GLRX5 LNX2 HBD SLC16A1 MAP4K5 HBB HBG1 HBG2 EPB41	1.26e-07	199	180	9	da0fec0a492bc3827d9066d2590bcd466cd45564
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	MYH9 ANXA3 CNTN6 SHANK2 EGFR PRKG1 PATJ PARD3	4.74e-07	170	180	8	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANXA3 CNTN6 SHROOM4 SHANK2 EGFR STK33 CGNL1 PATJ	5.41e-07	173	180	8	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 VPS13C CEP350 CCT6A IBTK MACF1 TASOR GOLGA3	6.16e-07	176	180	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPC6 FHOD3 CNTN6 SHANK2 EGFR SRGAP3 PATJ DNAH5	6.71e-07	178	180	8	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	wk_15-18-Hematologic-Meg-ery-Definitive_reticulocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GLRX5 NATD1 HBB HBD USP15 HBG1 HBG2 EPB41	8.27e-07	183	180	8	5470e5ac3439cfc96acd2202f6b1e386779a6637
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_reticulocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GLRX5 NATD1 HBB HBD USP15 HBG1 HBG2 EPB41	9.35e-07	186	180	8	bf8ca7135c05d772aa3f5960b419a13aef3936ae
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 CDK17 VPS13C CHD1 EPG5 BRAF MACF1 TMEM131	1.01e-06	188	180	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	ANXA3 ANKS1B CNTN6 SHANK2 CGNL1 PATJ PARD3 CACNA2D3	1.05e-06	189	180	8	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 MYH10 TRPC6 ABCA10 FREM1 PKD2 MACF1 PRKG1	1.14e-06	191	180	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SYNE1 ANXA3 SHANK2 EGFR PRKG1 CGNL1 PATJ PARD3	1.19e-06	192	180	8	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	LNX2 ANXA3 SHANK2 EGFR STK33 CGNL1 PATJ PARD3	1.19e-06	192	180	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	IPF-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	SH3TC2 ANXA3 NOMO1 EGFR SYNJ2 NOMO2 KCNJ2 NOMO3	1.19e-06	192	180	8	e911e286da26202853f9650ba3cdefe5a5c9b585
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A1 MYH10 TRPC6 ABCA10 FREM1 PKD2 MACF1 PRKG1	1.19e-06	192	180	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 SLC3A1 SHANK2 STK33 CGNL1 PATJ PRLR CACNA2D3	1.23e-06	193	180	8	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LNX2 SYNE1 SHANK2 EGFR PRKG1 CGNL1 PATJ PARD3	1.28e-06	194	180	8	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 SLC3A1 SHANK2 STK33 CGNL1 PATJ PARD3 CACNA2D3	1.28e-06	194	180	8	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RSPH4A SYNE1 RHPN1 STK33 SHOC1 DTHD1 CFAP44 DNAH5	1.28e-06	194	180	8	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 SHANK2 SRGAP3 STK33 CGNL1 PATJ PARD3 CACNA2D3	1.33e-06	195	180	8	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	Control-Epithelial\|Control / Disease state, Lineage and Cell class	SYNE1 SHANK2 EGFR STK33 CGNL1 PATJ PARD3 DNAH5	1.33e-06	195	180	8	1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	GLRX5 NATD1 HBD HBB USP15 HBG1 HBG2 EPB41	1.38e-06	196	180	8	092caba6726d1acd409a8be335100764d0724e64
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 LRRC9 RHPN1 SHANK2 STK33 DTHD1 CFAP44 DNAH5	1.44e-06	197	180	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	PBMC-Severe\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PADI4 MYH9 ANXA3 HBD RUFY1 B3GNT2 HBB HBG2	1.44e-06	197	180	8	3ff23b86d310ace388d2efb3ee73dd47c46f363e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYH10 ASIC2 SYNE1 DGKB SPTBN4 SHANK2 CSMD1 ATP2B1	1.49e-06	198	180	8	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LNX2 RASGRF1 SHROOM4 SHANK2 EGFR STK33 CGNL1 PARD3	1.55e-06	199	180	8	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 CDK17 SYNE1 BRAF MACF1 DTHD1 USP15 EPB41	1.55e-06	199	180	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	COVID-19-COVID-19_Mild-Myeloid-Neutrophil\|COVID-19_Mild / Disease, condition lineage and cell class	PADI4 ANXA3 ALPK1 TLR6 NSUN7 STAT5B KCNJ2 SIPA1L2	1.55e-06	199	180	8	9f6b6731186ef399f952a75879eba66fd8ed3494
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RSPH4A NSUN7 LRRC9 RHPN1 STK33 DTHD1 CFAP44 DNAH5	1.61e-06	200	180	8	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	PCSK2 ASIC2 SYNE1 ANKS1B SPTBN4 SHANK2 CSMD1 ATP2B1	1.61e-06	200	180	8	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	MYH9 VPS13C CHD1 BRAF MACF1 HBB USP15 EPB41	1.61e-06	200	180	8	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RSPH4A LRRC9 RHPN1 STK33 DTHD1 CFAP44 DNAH5	3.16e-06	154	180	7	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RSPH4A LRRC9 RHPN1 STK33 DTHD1 CFAP44 DNAH5	3.16e-06	154	180	7	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	COVID-19_Mild-PLT_0\|COVID-19_Mild / Disease Group and Platelet Clusters	GTPBP6 UBQLN4 ALPK1 DSN1 MACF1 HBG1 HBG2	4.98e-06	165	180	7	083a14d3b0162cee4e79f7398b8fb739582b39ff
ToppCell	Control\|World / group, cell type (main and fine annotations)	SYNE1 ANKS1B SHANK2 EGFR PATJ PARD3 CACNA2D3	5.61e-06	168	180	7	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GLRX5 SHOC1 HBB HBD HBG1 HBG2 EPB41	6.54e-06	172	180	7	cc1a45a35f78063b2a777ae905f70f894fbcb22f
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GLRX5 SHOC1 HBB HBD HBG1 HBG2 EPB41	6.54e-06	172	180	7	30c57f5ca2326e8d890d9aac8096c64e5b51a24f
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYROXD1 TRPC6 TBC1D32 MDN1 SRGAP3 NUP210 UBE3C	7.33e-06	175	180	7	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	mild_COVID-19-RBC\|World / disease group, cell group and cell class (v2)	GLRX5 MYH10 B4GAT1 HBD TBC1D32 HBB	8.17e-06	117	180	6	85210be67ddc31903764b7fa6d7029d9656753d3
ToppCell	IIH-CD8-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	CUL4A MYH3 TOPBP1 SHROOM4 B3GNT2 CEP152 HBB	8.80e-06	180	180	7	d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GLRX5 NATD1 HBB HBD HBG1 HBG2 EPB41	9.13e-06	181	180	7	577bf37a6594fad01251d2c66d8ccda8e949b6cf
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GLRX5 NATD1 HBB HBD HBG1 HBG2 EPB41	9.13e-06	181	180	7	f5dc7a650afe8837cb424981e50ad2c8b18c7c32
ToppCell	mild_COVID-19-RBC\|mild_COVID-19 / disease group, cell group and cell class (v2)	GLRX5 MYH10 B4GAT1 HBD TBC1D32 HBB	9.44e-06	120	180	6	cccea760901558ec18d5cbb71c7971c5a51da571
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	ANXA3 CNTN6 SHANK2 EGFR CGNL1 PATJ PARD3	9.46e-06	182	180	7	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FHOD3 SLC3A1 SHANK2 CGNL1 PATJ PRLR CACNA2D3	9.46e-06	182	180	7	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RASGRF1 SHROOM4 SHANK2 EGFR CGNL1 PATJ PARD3	9.80e-06	183	180	7	6847c1252d6bb105524f812658112517fd351eab
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	LNX2 SYNE1 SHANK2 PRKG1 CGNL1 PATJ PARD3	9.80e-06	183	180	7	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANXA3 CNTN6 SHANK2 EGFR CGNL1 PATJ PARD3	1.02e-05	184	180	7	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LNX2 ANXA3 CNTN6 ARRB1 SHANK2 CGNL1 PATJ	1.02e-05	184	180	7	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSPH4A FREM1 LRRC9 TBC1D32 STK33 DTHD1 DNAH5	1.02e-05	184	180	7	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C CHD1 HP1BP3 CEP350 CCT6A MACF1 TASOR	1.02e-05	184	180	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSPH4A FREM1 LRRC9 TBC1D32 STK33 DTHD1 DNAH5	1.02e-05	184	180	7	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANXA3 CNTN6 SHANK2 EGFR CGNL1 PATJ PARD3	1.02e-05	184	180	7	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSPH4A FREM1 LRRC9 TBC1D32 STK33 DTHD1 DNAH5	1.02e-05	184	180	7	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	PBMC-Severe-Hematopoietic-RBC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.05e-05	185	180	7	d685a5a2e525db2eba449cfa1e5cd54eb36162a8
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANXA3 CNTN6 SHANK2 EGFR CGNL1 PATJ CACNA2D3	1.05e-05	185	180	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	PBMC-Severe-Hematopoietic-RBC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.05e-05	185	180	7	5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04
ToppCell	PBMC-Severe-Hematopoietic-RBC-RBC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.05e-05	185	180	7	100b5afdf3c6ab07ffc493f7883f5a7b31c59184
ToppCell	COVID-19_Severe-Hematopoietic_R\|COVID-19_Severe / Disease group, lineage and cell class	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.05e-05	185	180	7	30f064ab7c3890e6f419a845276b145112e78f52
ToppCell	PBMC-Severe-Hematopoietic-RBC-RBC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.05e-05	185	180	7	f3b1907c3b6f930bc161f46efce5e143babab507
ToppCell	PBMC-Severe-Hematopoietic-RBC-RBC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.05e-05	185	180	7	44ce50cb99df8ffc50eba311adcf688477618659
ToppCell	PBMC-Severe-Hematopoietic-RBC-RBC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.05e-05	185	180	7	17542ccd52a821c9e99b1a7469e80502e764b3fd
ToppCell	wk_20-22-Hematologic-Meg-ery-Definitive_reticulocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NATD1 HBB HBD USP15 HBG1 HBG2 EPB41	1.05e-05	185	180	7	4a2c85e292d4cbce80e92992ded5d66a3aa446ee
ToppCell	COVID-19_Severe-Hematopoietic_R-RBC\|COVID-19_Severe / Disease group, lineage and cell class	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.05e-05	185	180	7	3ed6090b822c6d1d400a421236cddc7511743932
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PADI4 GLRX5 HBD HBB HBG1 HBG2 EPB41	1.09e-05	186	180	7	1c39ced3b32dba2832991284720b6c5f508a2e73
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CNTN6 SHANK2 EGFR IFT80 CGNL1 PATJ CACNA2D3	1.09e-05	186	180	7	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VPS13C DGKB NAV1 TNFAIP2 CSMD1 USP15 DNAH8	1.09e-05	186	180	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.09e-05	186	180	7	34ed60e846fd83fab3e28dc9e278bcc4b092a9f0
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.09e-05	186	180	7	40acd9b4e9b3c1d1527bd4ba17ae830ff18d6e9d
ToppCell	COVID-19-kidney\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FHOD3 SLC3A1 SHANK2 CGNL1 PATJ PRLR CACNA2D3	1.13e-05	187	180	7	d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	LNX2 ANXA3 CNTN6 SHANK2 CGNL1 PATJ CACNA2D3	1.13e-05	187	180	7	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	TRPC6 FHOD3 SHANK2 EGFR SRGAP3 PATJ DNAH5	1.13e-05	187	180	7	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	Endothelial-B-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	MYH10 ASIC2 PYROXD1 F8 SLC16A1 SRGAP3 PRKG1	1.17e-05	188	180	7	ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	CDK17 SYNE1 SHANK2 STK33 PATJ PARD3 DNAH5	1.17e-05	188	180	7	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	TRPC6 FHOD3 CEMIP EGFR SRGAP3 PATJ PARD3	1.25e-05	190	180	7	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP34 VPS13C SMARCAD1 HP1BP3 CEP350 CCT6A TASOR	1.29e-05	191	180	7	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANXA3 FSTL5 NSUN7 CNTN6 SHANK2 PATJ DNAH5	1.29e-05	191	180	7	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	ANXA3 SHROOM4 SHANK2 EGFR CGNL1 PATJ PARD3	1.29e-05	191	180	7	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LNX2 SHANK2 EGFR STK33 CGNL1 PATJ PARD3	1.29e-05	191	180	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP34 VPS13C SMARCAD1 HP1BP3 CEP350 CCT6A TASOR	1.29e-05	191	180	7	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	SH3TC2 NOMO1 SYNJ2 NOMO2 KCNJ2 CSMD1 NOMO3	1.34e-05	192	180	7	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MANBA NSD2 SYNE1 F8 CEP350 MACF1 TNFAIP2	1.34e-05	192	180	7	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 SHANK2 STK33 CGNL1 PATJ PARD3 PRLR	1.38e-05	193	180	7	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	LNX2 NATD1 HBB USP15 HBG1 HBG2 EPB41	1.38e-05	193	180	7	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCell	severe_influenza-RBC\|severe_influenza / disease group, cell group and cell class (v2)	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.38e-05	193	180	7	ffb0b3c2cce13b6891157f0fede2600f3938670e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TRPC6 ANKS1B FREM1 EGFR SRGAP3 MACF1 PRKG1	1.43e-05	194	180	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FHOD3 SLC3A1 SHANK2 SRGAP3 STK33 PATJ CACNA2D3	1.43e-05	194	180	7	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DSN1 FSIP2 TBC1D32 SYNJ2 DTHD1 HBG2 PRIMPOL	1.43e-05	194	180	7	8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	GLRX5 NATD1 HBD HBB HBG1 HBG2 EPB41	1.43e-05	194	180	7	f0ababe8daa57f6827a3e2e72c884d9e8b2687a3
ToppCell	COVID_vent-Myeloid-Monocytic-Neutrophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ANXA3 ALPK1 TLR6 NSUN7 ARRB2 KCNJ2 HBB	1.43e-05	194	180	7	eb23b171e429165dd26a64377eae7fa2ce25f547
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TRPC6 ANKS1B FREM1 EGFR SRGAP3 MACF1 PRKG1	1.48e-05	195	180	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
Drug	NMAM	F8 HBB HBD HBG1 HBG2	7.78e-08	15	178	5	CID000013543
Drug	dimethyl adipimidate	LCT SPTBN4 HBB HBD HBG1 HBG2	1.07e-07	30	178	6	CID000025738
Drug	LY83583	NUMA1 SLC3A1 KCNJ2 C2 PRKG1 HBB HBD HBG1 HBG2	1.41e-07	105	178	9	CID000003976
Drug	B0683	MYH2 MYH3 MYH6 MYH9 MYH10 MAP4K5 GLUD1 GLUD2 PKD2	3.57e-07	117	178	9	CID006398969
Drug	AC1NUW7G	UBQLN4 STT3A NOMO1 HBB HBD HBG1 HBG2	4.85e-07	61	178	7	CID005462208
Drug	phytate	MANBA PICALM SAG ARRB1 ARRB2 HBB HBD HBG1 HBG2 EPB41	5.17e-07	159	178	10	CID000000890
Drug	NSC339663	MYH2 MYH3 MYH6 MYH9 MYH10 SYNE1 ANKS1B SAG ARRB1 ARRB2 SHANK2 SORBS3	6.83e-07	250	178	12	CID000003892
Drug	NSC401575	MYH9 SYNE1 NUMA1 GFPT1 HBB HBD HBG1 HBG2 PRLR	8.17e-07	129	178	9	CID000003165
Drug	Glyset	MANBA LCT HBB HBD HBG1 HBG2	1.01e-06	43	178	6	CID000051577
Drug	syntometrine	HBB HBD HBG1 HBG2	1.14e-06	11	178	4	CID011979741
Drug	NFPLP	HBB HBD HBG1 HBG2	1.14e-06	11	178	4	CID006451852
Drug	N-(2-hydroxypropyl)valine	HBB HBD HBG1 HBG2	1.14e-06	11	178	4	CID000130204
Drug	Chlorocruorin	C2 HBB HBD HBG1 HBG2	1.29e-06	25	178	5	CID005748247
Drug	alpha-AASA	LCT C2 HBB HBD HBG1 HBG2	1.33e-06	45	178	6	CID000000207
Drug	2,3-DPG	KDM3A SPTBN4 C2 PRKG1 HBB HBD HBG1 HBG2 EPB41	1.35e-06	137	178	9	CID000000061
Drug	Ferastral	HBB HBD HBG1 HBG2	1.70e-06	12	178	4	CID000171553
Drug	2-hydroxylamino-5-ethyl-5-propylbarbituric acid	HBB HBD HBG1 HBG2	1.70e-06	12	178	4	CID000128182
Drug	7-methylguanosine 5'-phosphate	HBB HBD HBG1 HBG2	1.70e-06	12	178	4	CID000440190
Drug	HPED	SYNE1 HBB HBD	1.87e-06	4	178	3	CID000125856
Drug	ureidoglycine	GLUD1 GLUD2 C2	1.87e-06	4	178	3	CID000439649
Drug	pentafluorophenyl isothiocyanate	HBB HBD HBG1 HBG2	2.44e-06	13	178	4	CID000123452
Drug	3-aminobiphenyl	HBB HBD HBG1 HBG2	2.44e-06	13	178	4	CID000016717
Drug	6-amino-m-cresol	HBB HBD HBG1 HBG2	3.40e-06	14	178	4	CID000076082
Drug	Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; MCF7; HT_HG-U133A	IPO5 CDK17 MANBA ALPK1 STAT5B EGFR SYNJ2 PKD2 PATJ ATP2B1	3.46e-06	196	178	10	7224_DN
Drug	BW12C	HBB HBD HBG1 HBG2	4.61e-06	15	178	4	CID000072162
Drug	methyl acetyl phosphate	HBB HBD HBG1 HBG2	4.61e-06	15	178	4	CID000170449
Drug	2,2,2-trifluoroethanethiol	SAG ARRB1 ARRB2	4.64e-06	5	178	3	CID004133924
Drug	isosteviol lactone	LCT GLUD1 GLUD2	4.64e-06	5	178	3	CID000401559
Drug	aminobutyrate	MYH2 GLUD1 GLUD2 C2 HBB HBD HBG1 HBG2	4.76e-06	120	178	8	CID000006657
Drug	Gm(5')ppp	HBB HBD HBG1 HBG2	6.11e-06	16	178	4	CID000173813
Drug	AC1L3XKM	HBB HBD HBG1 HBG2	6.11e-06	16	178	4	CID000123930
Drug	colupulone	HBB HBD HBG1 HBG2	6.11e-06	16	178	4	CID000373677
Drug	2-methyleneglutarate	SYNE1 GFPT1 GLUD1 GLUD2	6.11e-06	16	178	4	CID000095155
Drug	N-(2-hydroxyethyl)valine	HBB HBD HBG1 HBG2	7.94e-06	17	178	4	CID000107912
Drug	Rsr 4	HBB HBD HBG1 HBG2	7.94e-06	17	178	4	CID000131347
Drug	ferric citrate	NOMO1 SHANK2 HBB HBD HBG1 HBG2	8.97e-06	62	178	6	CID000031083
Drug	SureCN2354151	SYNE1 EGFR RFXANK HBB HBD EPB41	8.97e-06	62	178	6	CID011978952
Drug	neokyotorphin	HBB HBD HBG1 HBG2	1.01e-05	18	178	4	CID000122173
Drug	AC1L1BA8	HBB HBD HBG1 HBG2	1.01e-05	18	178	4	CID000001351
Drug	PCMB	CYP8B1 LCT SLC16A1 GLUD1 GLUD2 HBB HBD HBG1 HBG2	1.16e-05	178	178	9	CID000001730
Drug	Hemorphin 7	HBB HBD HBG1 HBG2	1.28e-05	19	178	4	CID000132952
Drug	flourish	MANBA HBB HBD HBG1 HBG2	1.28e-05	39	178	5	CID000009291
Drug	S-(-)-Etomoxir	MYH2 MYH3 MYH6 MYH9 MYH10 KCNJ2 C2	1.38e-05	100	178	7	CID000060765
Drug	glucitollysine	HBB HBD HBG1 HBG2	1.59e-05	20	178	4	CID000122288
Drug	C19565	HBB HBD HBG1 HBG2	1.59e-05	20	178	4	CID000107819
Drug	sulfo-SADP	SAG ARRB1 ARRB2	1.61e-05	7	178	3	CID000128116
Drug	S-phenylcysteine	HBB HBD HBG1 HBG2	1.95e-05	21	178	4	CID000119462
Drug	iron phosphate	HBB HBD HBG1 HBG2	1.95e-05	21	178	4	CID000024861
Drug	Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ACTR8 PSMD11 STAT5B SHANK2 SLC16A1 FARS2 PKD2 MACF1 TNFAIP2	2.30e-05	194	178	9	7468_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	USP34 MICAL1 SH3TC2 ALPK1 CEMIP ARRB2 KCNJ2 NUP210 SORBS3	2.30e-05	194	178	9	4284_DN
Drug	3-iodo-4-hydroxybenzoic acid	HBB HBD HBG1 HBG2	2.37e-05	22	178	4	CID000449473
Drug	Cilag	HBB HBD HBG1 HBG2	2.37e-05	22	178	4	CID000070549
Drug	tellimagrandin I	HBB HBD HBG1 HBG2	2.37e-05	22	178	4	CID000442690
Drug	NSC69862	HBB HBD HBG1 HBG2	2.37e-05	22	178	4	CID000072284
Drug	Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A	USP34 MANBA SYNE1 ALPK1 F8 SYNJ2 NUP210 SORBS3 TNFAIP2	2.49e-05	196	178	9	7377_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	IPO5 USP34 MANBA ALPK1 ARRB2 SYNJ2 CEP152 PATJ PRLR	2.49e-05	196	178	9	6924_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	IPO5 CDK17 HBS1L NSD2 SYNJ2 B3GNT2 TNFAIP2 PATJ PARD3	2.59e-05	197	178	9	2285_DN
Drug	Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A	USP34 ACTR8 MANBA PSMD11 PICALM F8 STAT5B TNFAIP2 PRLR	2.70e-05	198	178	9	6523_DN
Drug	AC1L8FE9	HBB HBD HBG1 HBG2	2.85e-05	23	178	4	CID000425294
Drug	n-butyl isocyanide	HBB HBD HBG1 HBG2	2.85e-05	23	178	4	CID000076008
Drug	L-histidine beta-naphthylamide	HBB HBD HBG1 HBG2	2.85e-05	23	178	4	CID000110993
Drug	NSC-7813	HBB HBD HBG1 HBG2	2.85e-05	23	178	4	CID000407619
Drug	AC1L1IZ2	MYH2 MYH3 MYH6 MYH9 MYH10 RBL2 ANKS1B ARRB1 EGFR KCNJ2 PRKG1	2.90e-05	304	178	11	CID000004795
Drug	propylene oxide	C2 HBB HBD HBG1 HBG2	2.92e-05	46	178	5	CID000006378
Drug	ferric pyrophosphate	HBB HBD HBG1 HBG2	3.40e-05	24	178	4	CID000024877
Drug	vinyl	SYNE1 UBQLN4 F8 HBB HBD HBG1 HBG2	3.42e-05	115	178	7	CID000123166
Drug	Hb H	HBB HBD HBG1 HBG2 EPB41	3.60e-05	48	178	5	CID000466959
Drug	AC1L9FD9	SLC16A1 HBB HBD HBG1 HBG2	3.60e-05	48	178	5	CID000443871
Drug	boron	SYNE1 NUMA1 STAT5A STAT5B EGFR HBB HBD HBG1 HBG2 PRLR	3.65e-05	257	178	10	CID005462311
Drug	AC1L1GWH	LCT GLUD1 GLUD2	3.81e-05	9	178	3	CID000003872
Drug	Vv-hemorphin-7	HBB HBD HBG1 HBG2	4.02e-05	25	178	4	CID000126533
Drug	E 64	CAPN1 CAPN11 SPPL2A HBB HBD HBG1 HBG2 EPB41	4.05e-05	161	178	8	CID000123985
Drug	phosphoenolpyruvate	SLC3A1 ITPA GLUD1 GLUD2 C2 HBB HBD HBG1 HBG2	4.27e-05	210	178	9	CID000001005
Drug	DNME	HBB HBD HBG1 HBG2	4.72e-05	26	178	4	CID005464045
Drug	thiohydantoin	HBB HBD HBG1 HBG2	4.72e-05	26	178	4	CID001274030
Drug	iron (II) d-gluconate dihydrate	HBB HBD HBG1 HBG2	4.72e-05	26	178	4	CID000071372
Drug	benzyl alcohol	SLC3A1 C2 HBB HBD HBG1 HBG2	4.81e-05	83	178	6	CID000000244
Drug	formycin triphosphate	MYH2 MYH3 MYH6 MYH9 MYH10	4.85e-05	51	178	5	CID000122274
Drug	S884	GLUD1 GLUD2 C2	5.42e-05	10	178	3	CID004685067
Drug	2,7-diaminofluorene	HBB HBD HBG1 HBG2	5.51e-05	27	178	4	CID000010679
Drug	singlet oxygen	PADI4 SYNE1 STT3A NOMO1 C2	5.85e-05	53	178	5	CID000159832
Drug	neoR	PCSK2 PRKG1 HBB HBD HBG1 HBG2	5.88e-05	86	178	6	CID000496913
Drug	phenyltriethoxysilane	GLUD1 GLUD2	6.08e-05	2	178	2	CID000013075
Drug	tricapryl(methyl)ammonium	HBB HBD	6.08e-05	2	178	2	CID011071504
Drug	allyl 2,4,6-tribromophenyl ether	HBB HBD	6.08e-05	2	178	2	CID000076767
Drug	1,3,5-tribromobenzene	HBB HBD	6.08e-05	2	178	2	CID000012279
Drug	G-3SH	GLUD1 GLUD2	6.08e-05	2	178	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	6.08e-05	2	178	2	CID006455327
Drug	Hexachlorophene	GLUD1 SDHD	6.08e-05	2	178	2	DB00756
Drug	2-(alpha-hydroxybenzyl)-benzimidazole	HBB HBD	6.08e-05	2	178	2	CID000005792
Drug	NSC-334295	HBB HBD	6.08e-05	2	178	2	CID000100107
Drug	methylmercuric bromide	GLUD1 GLUD2	6.08e-05	2	178	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	6.08e-05	2	178	2	CID000068137
Drug	DA 8	MYH3 KCNJ2	6.08e-05	2	178	2	CID005288074
Drug	x 1 s	GLUD1 GLUD2	6.08e-05	2	178	2	CID000409694
Drug	AC1L3OJQ	HBB HBD	6.08e-05	2	178	2	CID000119294
Drug	pentabromobenzene	HBB HBD	6.08e-05	2	178	2	CID000011854
Drug	tribromobenzene	HBB HBD	6.08e-05	2	178	2	CID000011842
Drug	Bromkal 73-5 PE	HBB HBD	6.08e-05	2	178	2	CID000118216
Drug	SM-2	MYH2 MYH3 MYH6 MYH10 GLUD1 GLUD2	6.27e-05	87	178	6	CID000486033
Disease	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	HBB HBG1 HBG2	2.02e-07	3	174	3	141749
Disease	delta beta-thalassemia (is_implicated_in)	HBB HBG1 HBG2	2.02e-07	3	174	3	DOID:0080773 (is_implicated_in)
Disease	Delta-Beta Thalassemia	HBB HBD HBG1	2.02e-07	3	174	3	C0271985
Disease	Hereditary persistence of fetal hemoglobin	HBB HBG1 HBG2	2.02e-07	3	174	3	cv:C0019025
Disease	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	HBB HBG1 HBG2	8.03e-07	4	174	3	C1841621
Disease	hemoglobin measurement, hemoglobin A2 measurement	HBS1L HBD HBD	2.00e-06	5	174	3	EFO_0004509, EFO_0005845
Disease	hemoglobin E disease	HBS1L HBD HBD	3.98e-06	6	174	3	MONDO_0016243
Disease	Thromboembolism	HBD CSMD1 HBD HBG1 HBG2	6.07e-06	44	174	5	HP_0001907
Disease	Malignant neoplasm of breast	KDM3A MICAL1 MYH9 B4GAT1 NSD2 SYNE1 RUFY1 CNTN6 STAT5A EPG5 DDX10 KMT2D BRAF EGFR SYNJ2 UNC45B SRGAP3 MACF1 NLRP8	2.10e-05	1074	174	19	C0006142
Disease	calcium measurement	ASIC2 NUMA1 RREB1 SAG SPPL2A EBLN1 MAP4K5 SHOC1 KIF14 MACF1 TMEM131 PRKG1 CGNL1 ATP2B1	2.34e-05	628	174	14	EFO_0004838
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH3 MYH6	2.35e-05	10	174	3	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH3 MYH6	2.35e-05	10	174	3	DOID:0111596 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH3 MYH6	2.35e-05	10	174	3	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH3 MYH6	2.35e-05	10	174	3	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH3 MYH6	2.35e-05	10	174	3	DOID:0111605 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	2.35e-05	10	174	3	DOID:0111269 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH3 MYH6	2.35e-05	10	174	3	DOID:0110454 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	2.35e-05	10	174	3	DOID:0080326 (implicated_via_orthology)
Disease	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	B4GAT1 B3GNT2	3.46e-05	2	174	2	C3809042
Disease	asphyxiating thoracic dystrophy (implicated_via_orthology)	SMARCAD1 IFT80	3.46e-05	2	174	2	DOID:0050592 (implicated_via_orthology)
Disease	Chloracne	EGFR HBB HBD HBG1	4.18e-05	33	174	4	C0263454
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH3 MYH6	4.26e-05	12	174	3	DOID:2106 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	4.26e-05	12	174	3	DOID:11720 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	5.52e-05	13	174	3	DOID:397 (implicated_via_orthology)
Disease	Prescription Drug Abuse	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C4316881
Disease	Substance-Related Disorders	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C0236969
Disease	Organic Mental Disorders, Substance-Induced	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C0029231
Disease	Drug habituation	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C0013170
Disease	Drug abuse	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C0013146
Disease	Drug Use Disorders	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C0013222
Disease	Drug Dependence	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C1510472
Disease	Substance Dependence	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C0038580
Disease	Substance Use Disorders	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.38e-05	115	174	6	C0038586
Disease	cardiomyopathy (implicated_via_orthology)	MYH2 MYH3 MYH6 BRAF EGFR	6.40e-05	71	174	5	DOID:0050700 (implicated_via_orthology)
Disease	Substance abuse problem	SYNE1 FHOD3 EIPR1 CSMD1 PATJ DNAH8	6.69e-05	116	174	6	C0740858
Disease	severe acute respiratory syndrome, COVID-19	DGKB CNTN6 SYNJ2 FARS2 SRGAP3 NUP210 CSMD1 PATJ PARD3 SIPA1L2 CACNA2D3	7.52e-05	447	174	11	EFO_0000694, MONDO_0100096
Disease	urate measurement, bone density	ASIC2 SYNE1 FSTL5 TRPC6 FREM1 DDX10 FSIP2 MAP4K5 NAV1 KIF14 C2 SLC30A9 DNAH8	8.40e-05	619	174	13	EFO_0003923, EFO_0004531
Disease	Hemoglobin F Disease	HBB HBG1 HBG2	8.70e-05	15	174	3	C0019025
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH3 MYH6	8.70e-05	15	174	3	DOID:0050646 (implicated_via_orthology)
Disease	ciliopathy (implicated_via_orthology)	MAP4K5 PRKG1 IFT80 SCLT1	9.04e-05	40	174	4	DOID:0060340 (implicated_via_orthology)
Disease	beta thalassemia (implicated_via_orthology)	HBB HBD	1.03e-04	3	174	2	DOID:12241 (implicated_via_orthology)
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	1.03e-04	3	174	2	DOID:885 (biomarker_via_orthology)
Disease	hemoglobin measurement, fetal hemoglobin measurement	HBS1L HBG2	2.06e-04	4	174	2	EFO_0004509, EFO_0004576
Disease	amyloid-beta measurement	HBS1L ASIC2 RREB1 ABCA10 SHOC1 CGNL1 CSMD1 PRLR CACNA2D3	2.74e-04	355	174	9	EFO_0005194
Disease	fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement	VPS13C MAP4K5	3.42e-04	5	174	2	EFO_0004307, EFO_0004465, EFO_0004466
Disease	hereditary spastic paraplegia 76 (implicated_via_orthology)	CAPN1 CAPN11	3.42e-04	5	174	2	DOID:0110821 (implicated_via_orthology)
Disease	Cetuximab response	BRAF EGFR	3.42e-04	5	174	2	cv:CN077967
Disease	Panitumumab response	BRAF EGFR	3.42e-04	5	174	2	cv:CN077999
Disease	alpha-linolenic acid measurement	PDXDC1 LCT CSMD1	4.21e-04	25	174	3	EFO_0007759
Disease	estradiol measurement	CNTN6 SPPL2A SHANK2 MAP4K5 NAV1	5.00e-04	110	174	5	EFO_0004697
Disease	Carcinoma, Lobular	MYH9 STAT5A	5.11e-04	6	174	2	C0206692
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	5.11e-04	6	174	2	DOID:1825 (biomarker_via_orthology)
Disease	Sezary Syndrome	KMT2D BRAF PRKG1	5.31e-04	27	174	3	C0036920
Disease	Bipolar Disorder	RASGRF1 SPR SYNE1 FSTL5 DGKB CNTN6 ARRB2 SHANK2 CSMD1 DNAH8	5.66e-04	477	174	10	C0005586
Disease	Hyalinosis, Segmental Glomerular	MYH9 MYH10 TRPC6	5.92e-04	28	174	3	C0086432
Disease	neuroblastoma	LRRC45 DGKB FARS2 CSMD1 DNAH5	6.37e-04	116	174	5	EFO_0000621
Disease	anemia (biomarker_via_orthology)	HBB HBD	7.12e-04	7	174	2	DOID:2355 (biomarker_via_orthology)
Disease	Pilomyxoid astrocytoma	BRAF SRGAP3	7.12e-04	7	174	2	C1519086
Disease	Headache, fasting blood glucose measurement	MANBA UBE3C	7.12e-04	7	174	2	EFO_0004465, HP_0002315
Disease	chronic obstructive pulmonary disease	DCHS2 MYH9 DGKB RREB1 PICALM SPPL2A SRGAP3 NAV1 DTHD1 SCLT1 DNAH5 CACNA2D3	8.30e-04	688	174	12	EFO_0000341
Disease	cholesteryl ester 22:6 measurement	EGFR SRGAP3 CSMD1	8.81e-04	32	174	3	EFO_0010350
Disease	Familial hyperinsulinism	SLC16A1 GLUD1	9.46e-04	8	174	2	cv:C3888018
Disease	hemoglobin A2 measurement	HBS1L HBB	9.46e-04	8	174	2	EFO_0005845
Disease	serum gamma-glutamyl transferase measurement	ANXA3 GON4L RREB1 SPPL2A SYNJ2 MAP4K5 TNFAIP2 IFT80 CGNL1 CSMD1 PARD3 SIPA1L2 GCN1 SDHD	1.09e-03	914	174	14	EFO_0004532
Disease	Malignant neoplasm of prostate	ANXA3 CHD1 SMARCAD1 TLR6 KMT2D BRAF EGFR PATJ PARD3 HBG1 HBG2	1.13e-03	616	174	11	C0376358
Disease	Prostatic Neoplasms	ANXA3 CHD1 SMARCAD1 TLR6 KMT2D BRAF EGFR PATJ PARD3 HBG1 HBG2	1.13e-03	616	174	11	C0033578
Disease	synaptotagmin-11 measurement	GON4L RREB1	1.21e-03	9	174	2	EFO_0802108
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	CAPN1 CAPN11 EML1	1.25e-03	36	174	3	DOID:11723 (implicated_via_orthology)
Disease	Focal glomerulosclerosis	MYH9 MYH10 TRPC6	1.25e-03	36	174	3	C0017668
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH2 MYH3 MYH6 EGFR	1.30e-03	80	174	4	DOID:12930 (implicated_via_orthology)
Disease	osteoarthritis, hand	MYH2 ASIC2 DNAH8	1.35e-03	37	174	3	EFO_1000789
Disease	Intellectual Disability	SPR NSD2 SYNE1 GON4L STT3A SHROOM4 SHANK2 SRGAP3 MACF1	1.41e-03	447	174	9	C3714756
Disease	thyroid gland papillary carcinoma (is_implicated_in)	KMT2D BRAF	1.51e-03	10	174	2	DOID:3969 (is_implicated_in)
Disease	beta thalassemia (is_implicated_in)	HBS1L HBB	1.51e-03	10	174	2	DOID:12241 (is_implicated_in)
Disease	lactate measurement	HBS1L MAP4K5 CGNL1	1.58e-03	39	174	3	EFO_0007745
Disease	atrial fibrillation	CUL4A USP34 KDM3A MYH6 MANBA DGKB ALPK1 CGNL1	1.68e-03	371	174	8	EFO_0000275
Disease	valine measurement	MAP4K5 GLUD1 USP15	1.70e-03	40	174	3	EFO_0009792
Disease	kidney disease (implicated_via_orthology)	MYH9 TRPC6 LCT	1.82e-03	41	174	3	DOID:557 (implicated_via_orthology)
Disease	cognitive decline measurement, memory performance, language measurement	MYH9 TNFAIP2	1.84e-03	11	174	2	EFO_0004874, EFO_0007710, EFO_0007797
Disease	response to radiation	EPG5 SPPL2A CSMD1 DNAH5	1.85e-03	88	174	4	GO_0009314
Disease	diffuse plaque measurement	DCHS2 HBS1L GLRX5 ANKS1B ARRB1 SHANK2 FARS2 KCNJ2 MACF1 PRKG1 TRIM38 CACNA2D3	1.88e-03	758	174	12	EFO_0010699
Disease	liver fat measurement	MAP4K5 TOR1B LMBRD1	2.09e-03	43	174	3	EFO_0010821
Disease	intracranial aneurysm (is_implicated_in)	KMT2D PKD2	2.19e-03	12	174	2	DOID:10941 (is_implicated_in)
Disease	mean corpuscular hemoglobin concentration	CUL4A MYH2 HBS1L GLRX5 GON4L RREB1 STT3A EGFR MAP4K5 B3GNT2 MACF1 UBE3C HBB HBG2 EPB41	2.38e-03	1105	174	15	EFO_0004528
Disease	amino acid measurement	IPO5 GLRX5 MYH10 SYNE1 DGKB MAP4K5 GLUD1 AIFM3 PRKG1 CSMD1 HBG2	2.39e-03	678	174	11	EFO_0005134
Disease	FEV/FEC ratio	USP34 DCHS2 MYH9 VPS13C ANKS1B PRXL2A DGKB RREB1 SRGAP3 NAV1 CSMD1 PARD3 DTHD1 DNAH5 ATP2B1 CACNA2D3	2.58e-03	1228	174	16	EFO_0004713
Disease	phosphatidylcholine 40:7 measurement	PDXDC1 NOMO1	2.58e-03	13	174	2	EFO_0021477
Disease	gamma-glutamylleucine measurement	FARS2 PRKG1	2.58e-03	13	174	2	EFO_0021140
Disease	urate measurement	USP34 CAPN1 UBQLN4 PRXL2A GON4L RREB1 CEMIP SPPL2A SHANK2 MAP4K5 PKD2 NAV1 HBB	2.60e-03	895	174	13	EFO_0004531
Disease	glutamine measurement	CNTN6 MAP4K5 HOGA1 GLUD1	2.64e-03	97	174	4	EFO_0009768
Disease	Atrial Fibrillation	CUL4A USP34 MYH6 DGKB KCNJ2	2.65e-03	160	174	5	C0004238
Disease	Alzheimer disease, APOE carrier status	FSTL5 TRPC6 GFPT1 PRKG1	2.74e-03	98	174	4	EFO_0007659, MONDO_0004975
Disease	myopathy (implicated_via_orthology)	MYH2 MYH3 MYH6	2.87e-03	48	174	3	DOID:423 (implicated_via_orthology)
Disease	Neoplasm of lung	BRAF EGFR	3.00e-03	14	174	2	cv:C0024121
Disease	Lung cancer	BRAF EGFR	3.00e-03	14	174	2	cv:C0242379
Disease	LUNG CANCER	BRAF EGFR	3.00e-03	14	174	2	211980
Disease	triacylglycerol 46:2 measurement	MAP4K5 CSMD1	3.00e-03	14	174	2	EFO_0010402
Disease	triacylglycerol 52:1 measurement	MAP4K5 CSMD1	3.00e-03	14	174	2	EFO_0010413
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	SYNE1 ANKS1B STT3A CSMD1	3.06e-03	101	174	4	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	malaria	MYH3 CSMD1 HBB HBG2	3.17e-03	102	174	4	EFO_0001068

Protein segments in the cluster

Peptide	Gene	Start	Entry
AGDIKLTKDGNVLLH	CCT6A	51	P40227
YGVDLHKAKDLEGVD	EPB41	396	P11171
LHESFKDKLLPGDAG	EPG5	2011	Q9HCE0
LTQEHIEALLDKFGG	BRAF	56	P15056
GGFGLHKKKDLLSDN	CEP152	1471	O94986
QGDIHGKDFGKFKLE	CSMD1	3451	Q96PZ7
KEHFKGQQFLLEEGD	CRYBG3	2531	Q68DQ2
HLELYAAVKGLGKED	ABCA10	1301	Q8WWZ4
GAHIIAQFSKKLLDE	TBC1D32	581	Q96NH3
LNEGFLVHKGFKEAL	B4GAT1	366	O43505
GKVLLVKDNGEFHAL	AIFM3	91	Q96NN9
GKALGLDKAILHSID	ACTR8	506	Q9H981
KELKDDLKGDLSGHF	ANXA3	66	P12429
GIALDGKIKHEDTNL	SAG	296	P10523
DFLHLFKIVAGEGKE	CAPN11	571	Q9UMQ6
KDGKLVFVHSAEGNE	CAPN1	171	P07384
HGDALQKAAKAGLLA	SDHD	116	O14521
ALGFKAAHLEGTELK	CEMIP	531	Q8WUJ3
GSIKGELRKQALDHF	CHD1	836	O14646
NAAKKEEELGHLDSL	CFAP44	1191	Q96MT7
GLALDGKLKHEDTNL	ARRB1	286	P49407
RGLALDGKLKHEDTN	ARRB2	286	P32121
LGGKALHKELETQLL	ACTR10	166	Q9NZ32
LKFLKEAGHGTQKEE	ATP2B1	1066	P20020
LDKLILHGQGDFQKI	ALPK1	441	Q96QP1
KLLDLLGKEEDEGSH	ASIC2	461	Q16515
GAQLIHADKLGEKVE	HP1BP3	21	Q5SSJ5
KLIEIHGKAGLFLEG	NOMO3	791	P69849
ERFQEITGKLGHFLK	HBS1L	416	Q9Y450
IALLHGDLDASKEGK	KCNJ2	106	P63252
HLLQILEKGFKDSET	LRRC9	486	Q6ZRR7
SLHDGLVLEAKGIKE	RBL2	281	Q08999
KGSALHEAALFGKVD	ANKS1B	226	Q7Z6G8
FKDLEGNSLKDSGHE	PCDH19	896	Q8TAB3
NEGHGEALLFEGIKK	PADI4	506	Q9UM07
DDESGQKKLHGLQAI	NUP210	831	Q8TEM1
GVKKDLHDANTDLIG	SLC16A1	221	P53985
HGGEISKNKEFALAD	PAN2	771	Q504Q3
GQLAVLKGSKLHFLE	KIF14	1386	Q15058
KLIEIHGKAGLFLEG	NOMO2	791	Q5JPE7
KGLSLGFLEKKHDEA	MDN1	2896	Q9NU22
EVDYGKLEENLHKLG	HOGA1	51	Q86XE5
GHKKIIENELEGFGI	DRG1	156	Q9Y295
LIFGKGNFEHLTEKI	GTPBP6	151	O43824
HLSLAENALKDEGAK	NLRP8	871	Q86W28
LKHGVSLYIQDKEGL	IBTK	106	Q9P2D0
FKHLIGGLDDVSNKA	PRKG1	321	Q13976
KVKSLFEELGSSHGL	LMBRD1	176	Q9NUN5
LGSKKDGERHAFILQ	C2	426	P06681
LVQKEFLHGTKRDDG	KIAA1109	1261	Q2LD37
ALHKRDSGEQLGIKL	LNX2	341	Q8N448
ALKQHGLDLAVDKES	FSIP2	4381	Q5CZC0
HTKVFFKAGLLGLLE	MYH2	766	Q9UKX2
GENIHAGLLKKLNEL	PDXDC1	541	Q6P996
KHREFQALIKGGAAL	DNAH8	3776	Q96JB1
GRDKDHLLKYNVGDL	NSD2	211	O96028
ELKGLFHFEEGIQKL	FREM1	2016	Q5H8C1
KLIEIHGKAGLFLEG	NOMO1	791	Q15155
ELLHALGFSGQLFKK	LMLN2	306	A0A1B0GTW7
KQLLKGSADFLGLSH	LCT	671	P09848
ISHKGAEELALALKG	LRRC45	156	Q96CN5
AAADFATHGKLGKLE	MICAL1	336	Q8TDZ2
ATHGKLGKLEFAQDA	MICAL1	341	Q8TDZ2
HFSKKGEEENLEGLG	F8	1286	P00451
GGFKLAHGLLEELKT	GCN1	596	Q92616
NEVKVLLQGKGDSEH	MYH9	1231	P35579
INEKGELKLADFGLA	CDK17	321	Q00537
NNEHFEELGGILKAK	IPO5	786	O00410
EELGGILKAKLEEHF	IPO5	791	O00410
NELVDDLFKGAKEHG	NSFL1C	116	Q9UNZ2
ALELEHEKGKLTGLG	GOLGA3	1111	Q08378
GRGIAKHLAKAALDF	NATD1	66	Q8N6N6
GDGKKIISLADNHIL	EIPR1	146	Q53HC9
AKLDKAQIHDFVLGG	HSPA7	326	P48741
DVNLKYEKLGGVLHE	MACF1	4441	Q9UPN3
GFILHKDEAALQKID	FSTL5	616	Q8N475
NGKLHFSIVADDKDG	DCHS2	1436	Q6V1P9
AAQKAVLDLHGKSID	PABPC5	251	Q96DU9
FDGLHKALLSVGVSK	EBLN1	86	P0CF75
FGLAKLLGAEEKEYH	EGFR	856	P00533
LGDGKFLSHKNEILE	IFT80	451	Q9P2H3
NGDLVEELKKLGIHS	GLRX5	131	Q86SX6
LGIHSALLDEKKDQD	GLRX5	141	Q86SX6
SHLLKGDKNLVGSEV	KDM3A	181	Q9Y4C1
GLEDAVNEAKHLGVK	COL6A1	171	P12109
KDGNFLELGKEFILA	CACNA2D3	141	Q8IZS8
LLHEGKNGVLDRKDG	CGNL1	121	Q0VF96
KELEDFKLQHGSILG	GLUD1	346	P00367
TTLGHAVLKAEFKEG	CUL4A	571	Q13619
SLGDAIKHLDDLKGT	HBG1	71	P69891
KHFADGLETDGTLQK	DSN1	176	Q9H410
FQDDAGRGKKHSIIL	FHOD3	86	Q2V2M9
FTKAEDNLLALGLKH	GON4L	826	Q3T8J9
DNLLALGLKHFEGTE	GON4L	831	Q3T8J9
LLDEEKAERGSHQGK	CEP350	1196	Q5VT06
TKKLKDVLEEFHGNG	DGKB	26	Q9Y6T7
EGENKKKELFLTHGN	HAUS3	456	Q68CZ6
FFNGDVIDLKKGVAH	CNTN6	536	Q9UQ52
DLSQVLKDLHLEGFG	DTHD1	531	Q6ZMT9
LFELDGGLNIEKSAK	MANBA	306	O00462
KPEGLHQLLAGFEDK	ITPA	96	Q9BY32
DLAKGHIKALQEGDL	EXOC1	281	Q9NV70
KKLLSTGDDFGKVHL	EML1	751	O00423
HNVFGLDLKDEKTLQ	DDX10	641	Q13206
KKVLGAFSDGLAHLD	HBD	66	P02042
KKVLGAFSDGLAHLD	HBB	66	P68871
SLGDAIKHLDDLKGT	HBG2	71	P69892
QFKELLEDHGLLAGA	DHX34	686	Q14147
KELEDFKLQHGSILG	GLUD2	346	P49448
AGEHLKSDLLLEGFN	MYH10	291	P35580
ASTKHLRGDGLKDLN	CYP8B1	126	Q9UNU6
KHEEFLTLIKGGASL	DNAH5	3911	Q8TE73
DHFVLSLVNKDGIKG	PRIMPOL	381	Q96LW4
IKGANILLTDHGDVK	MAP4K5	141	Q9Y4K4
GHELQQAGLKTKEAE	NUMA1	1656	Q14980
LEKGGKAEHENLFRE	PARD3	306	Q8TEW0
GELDQLKEHLRKGDN	RFXANK	101	O14593
HIIKGDLKQQEFFLG	NAV1	1431	Q8NEY1
KQKALFLQGHLEGVD	RSPH4A	286	Q5TD94
EAGLGLKSNELKSHI	TRIM38	216	O00635
KHLVSEGDLLKDQRG	STK40	221	Q8N2I9
EDGELKEILDRKGHF	STK33	196	Q9BYT3
KGKILHFLQDASIGE	SMARCAD1	386	Q9H4L7
KGLGTVKDSLFFLHE	SYNE1	7291	Q8NF91
DFHQFAKGGKLEKLE	SYNJ2	336	O15056
DYTVNLGGLKDHIKE	GFPT1	366	Q06210
EFLKDHSQGGISVDK	NSUN7	396	Q8NE18
LKDVQDLDGGKEHER	RUFY1	286	Q96T51
DKKFHGILDQGEGVL	PSMD11	371	O00231
LLLYGADIESKNKHG	POTEJ	221	P0CG39
TYHLTKELKDAGAGL	STT3A	131	P46977
LKLDEQGLSFQHKIG	SIPA1L2	596	Q9P2F8
TNKHGIEDIGDIKFS	SHOC1	226	Q5VXU9
LDLLGDFKHALKKSE	SHROOM4	1021	Q9ULL8
DKGEGLIFEHNTKNL	SLC3A1	641	Q07837
HKGSALLEKAGALLA	SH3TC2	586	Q8TF17
KAEHQVGEDGFLLKI	STAT5B	71	P51692
HRLDEAEQLALKGGK	MYH3	1796	P11055
LEEEGKAKNALAHAL	MYH6	1321	P13533
AKGSGQDIDHLDFKI	RASGRF1	536	Q13972
GKAHLKRAILGQEEA	RHPN1	406	Q8TCX5
LGGILKAKLEGHFKN	RANBP6	801	O60518
KQGILLEHREKEFGD	PRXL2A	191	Q9BRX8
VEVIKALKNGGAHLD	SHANK2	211	Q9UPX8
NLLKLKASFNLEDGH	STRA8	106	Q7Z7C7
KAEHQVGEDGFLLKI	STAT5A	71	P42229
KAGVQEFVDGLHEKL	TASOR	1071	Q9UK61
KAKDLFIGDVIHNAG	B3GNT2	266	Q9NY97
DALEQHLASLEGKKI	PICALM	276	Q13492
ALEHLGKLDQAFKDV	UNC45B	86	Q8IWX7
DFSKGHLSAILAIKG	TNFAIP2	606	Q03169
LSQLQKGDKGEKHFE	ZNF33B	316	Q06732
GFHRDLLIKVKFGES	PIGX	56	Q8TBF5
LQAKHDLLKQTLGEG	SRGAP3	456	O43295
EGLNLKGTKEFSHKI	PYROXD1	241	Q8WU10
KGFLALLGLQHTKDV	RREB1	361	Q92766
ELHIIELEKDKNGLG	PATJ	1236	Q8NI35
LLSLLEKDEFKSGAH	SPR	241	P35270
LKGDDLGQKVLFRDH	PPM1M	286	Q96MI6
HFLEKARIAQKGGAE	SPPL2A	96	Q8TCT8
LTAKKLEGIHDGAIQ	TMEM131	636	Q92545
IKGFDAHLLEKGKSE	PRLR	276	P16471
LKDGDAQSLKEHLID	USP15	71	Q9Y4E8
DDLLQKHGLLEGDIA	SPTBN4	571	Q9H254
GSDLLENHIKKLEGE	VPS13C	3616	Q709C8
KGDLEVELSFRKGEH	SORBS3	466	O60504
TEYDKHLGELNGQLK	SCLT1	61	Q96NL6
LDKFLEEAKQHGGSK	SNW1	501	Q13573
LNFDELRQDLKGKGH	PKD2	736	Q13563
LRQDLKGKGHTDAEI	PKD2	741	Q13563
NLVELAELELKHAKG	SNX6	376	Q9UNH7
GNEFAVDKSKRGLIH	TLR6	31	Q9Y2C9
HDVKATDLGLGKVRF	SLC30A9	476	Q6PML9
EEKKLGILGSHEDLS	TRPC6	806	Q9Y210
GDGLQLRKEHTLKIF	USP34	21	Q70CQ2
EEEIVHKLLGDKFKG	SMYD5	201	Q6GMV2
SKHELFAGIKDGESL	FARS2	201	O95363
LKDGDTLNQHGIKDG	UBQLN4	61	Q9NRR5
LLYGADIESKNKHGL	POTEH	296	Q6S545
HLFSDLNKLKPDDSG	TOPBP1	1436	Q92547
KEKGHSEGRLLSFLE	UIMC1	616	Q96RL1
SALKLDLEEKLFGQH	TOR1B	66	O14657
LGGASRKEEKASLLH	UBE3C	16	Q15386
IQGLGLYAAKDLEKH	KMT2D	5406	O14686
EIFNLELAETKLGHG	MYO7B	591	Q6PIF6
TNHFLVELHKGGEDK	PCSK2	31	P16519